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ABSTRACT 
 
Molecular and In Vitro Growth Comparisons of Encephalitozoon hellem Isolates from 
Human and Bird Hosts.  (May 2003) 
Paulette Francesca Waters, B.S., Texas A&M University 
Chair of Advisory Committee:  Dr. Patricia Holman 
Molecular and in vitro comparisons were performed using two isolates of 
Encephalitozoon hellem, one from an avian host and one from a human host, and one 
isolate of Encephalitozoon cuniculi from a rabbit.  The molecular comparisons were 
performed by amplifying and sequencing the gene coding for a zinc metallo-
aminopeptidase from cDNA and gDNA obtained from each of the isolates.  The 
E. hellem sequences shared >99 % identity between each other and 70% identity with 
the E. cuniculi sequences.  Conserved HEXXH and GXMEN motifs located within the 
sequences classify the protein as an aminopeptidase of the M1 family, with at least one 
zinc atom required for catalytic activity.     
In vitro growth comparisons of the isolates described above were performed 
under simulated “mammalian and avian conditions”.  The models utilized mammalian 
and avian cell lines and sera at incubation temperatures of 37 °C and 40 °C, 
respectively.  Three separate experiments were performed.  E. cuniculi grew best under 
the mammalian model and significantly better than both E. hellem isolates under this 
model.  The E. hellem isolates were able to infect and replicate under both the 
mammalian and avian models, which reflects the zoonotic potential of these isolates.  
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CHAPTER I 
INTRODUCTION 
Microsporidia is a non-taxonomic designation that describes parasites 
belonging to the phylum Microspora.  Over 1000 different species have been 
identified belonging to approximately 140 genera.  Members of nearly every phylum 
of the animal kingdom may be infected by these obligately intracellular parasites 
including invertebrates, fish, mammals, birds, and man (reviewed by Weiss, 2001).  
Microsporidia are spore forming parasites that range in size from 1 to 12 µm. 
Spore shape is generally constant for members of the same genus.  The most common 
spore shape is oval, however, other spore shapes include rod-like and bent forms.  The 
spore wall consists of three regions: 1) an outer electron-dense exospore, 2) an 
electron-lucent endospore consisting of a protein-chitin complex, and 3) an inner 
membrane that surrounds the sporoplasm.  The exospore may be smooth or ridged, 
with or without filaments, tubular structures, or mucous coating containing filaments.  
A unique characteristic of microsporidia is the polar filament, also known as the polar 
tubule.  This filament encircles the infective parasitic cytoplasm, or sporoplasm, 
within the spore.   Depending on the species, the filament can form between 4 to 30 
coils in single or several rows.   Upon activation the polar filament is referred to as the 
polar tubule, which provides the means for infecting a new host cell (Vavra & 
Larsson, 1999).   
___________ 
This thesis follows the style and format of Parasitology. 
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The basic life cycle of microsporidia can be divided into three phases: 
infective, proliferative, and sporogonic.  The infective phase includes the spore in the  
environment until the sporoplasm is injected into the appropriate host cell. 
Germination of the spore may be induced by chemical or physical changes in the 
environment.  It is these changes that trigger the polar filament to evert into the polar 
tubule.  It is the polar tubule that is responsible for piercing the host cell and 
transferring the sporoplasm into the host cell.  Once the sporoplasm is injected into the 
appropriate host cell, the proliferative phase of the life cycle begins in which the 
sporoplasm replicates by merogony producing meronts.  Sporogony follows the 
proliferative phase, in which meronts develop into sporonts.  These sporonts replicate 
by binary or multiple fission into sporoblasts, which in turn develop into mature 
spores completing the life cycle (Cali & Takvorian, 1999).   
Microsporidia are classified as eukaryotic, possessing a nucleus with a nuclear 
envelope, an intracytoplasmic membrane system, and chromosome separation on 
mitotic spindles.  However, unlike eukaryotes, microsporidia lack mitochondria and 
centrioles (Weiss, 2001).  Microsporidian ribosomes resemble the 70S prokaryotic 
organelle, consisting of a large 23S subunit and a small 16S subunit (Weiss, 2000).  
Yet the rRNA genes of microsporidia are shorter than eukaryotic or prokaryotic genes 
(Vossbrinck et al. 1987).  Microsporidia also lack the 5.8S ribosomal RNA subunit 
and ITS2 region typical of eukaryotes.  Instead a region homologous to the 5.8S 
subunit is fused at the beginning of the large ribosomal subunit, which is a typical 
feature of bacteria (Peyretaillade et al. 1998).   
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The genomes of microsporidia are small, ranging from 2.3 to 19.5 Mb (Weiss 
& Vossbrinck, 1999).  The smallest eukaryotic genome yet described is that of the 
microsporidian Encephalitozoon intestinalis (2.3 Mb) (Peyretaillade et al. 1998).  
Analysis of the genome of Encephalitozoon cuniculi shows a low abundance of 
repetitive DNA and low gene copy number (Biderre et al. 1995).  Furthermore, only 
one intron in a microsporidian gene has been identified.  The intron is 28 base pairs 
long and located at the beginning of the large subunit ribosomal protein of E. cuniculi 
(Biderre, Metenier & Vivares, 1998).  This loss of genetic material is most reasonably 
connected with the obligate parasitism of these organisms (Biderre et al. 1995).  
The first microsporidian species to be recognized was Nosema bombycis, a 
parasite of silkworms, which devastated the silk industry in the early 19th century.  
Microsporidia were initially only known to be problematic in invertebrates and fish 
and not until later known to infect vertebrates and humans (Wittner, 1999). In 1922 
Wright and Craighead identified the first mammalian microsporidian infections in 
laboratory rabbits (Wright & Craighead, 1922).  Subsequently, in 1923 a new genus 
and species of microsporidia named Encephalitozoon cuniculi by Levaditi and others 
was recognized as the cause of encephalitis in laboratory rabbits (Wittner, 1999).  E. 
cuniculi has since been identified in numerous different mammals including humans, 
and other microsporidia species have since been reported in mammals and humans as 
well (reviewed by Deplazes, Mathis & Weber, 2000).   
A wide range of microsporidia has been successfully cultivated in vitro 
including those of invertebrate and vertebrate hosts.  Initially attention primarily 
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focused on microsporidia of economic importance such as Nosema apis, a parasite of 
honey bees, and Glugea stephani, a parasite of flounder (Visvesvara, 2002).  However, 
in 1969 the first culture of a mammalian microsporidia was established when 
Shadduck successfully continually propagated E. cuniculi of rabbit origin in rabbit 
kidney (RK) cells (Shadduck, 1969).  Between 1969 and 1990, E. cuniculi was the 
only microsporidia of mammalian origin cultivated in vitro (Visvesvara et al. 1999).  
In 1990 cultures of Vittaforma corneae from corneal scrapings of a human patient 
were established (Shadduck et al. 1990).  In 1991 Didier and others established 
continuous cultures of three Encephalitozoon hellem isolates from AIDS patients 
suffering from keratoconjunctivititis (Didier et al. 1991b).  
A number of isolates of E. cuniculi (Hollister et al. 1995; Deplazes et al. 1996; 
Mathis et al. 1997; Rossi et al. 1998; del Aguila et al. 2001) and E. hellem (Didier et 
al. 1991a; Hollister et al. 1993; Deplazes et al. 1998) have been established in culture.  
Isolates have been maintained in a variety of different cell types and media.  Different 
cell lines that have been used for the cultivation of Encephalitozoon spp. include 
rabbit kidney cells (RK), Madin-Darby canine kidney (MDCK), monkey kidney (E6), 
human lung fibroblast (HLF), lung fibroblasts (MRC-5), fetal bovine lung fibroblasts 
(FBF), and human colon carcinoma (Caco-2).  Also a variety of culture media has 
been used for propagating Encephalitozoon spp., including RPMI 1640, Eagle’s 
minimal essential medium (EMEM), and Dulbecco’s modified Eagle’s medium 
(DMEM), each supplemented with either 5 % or 10 % fetal bovine serum (FBS) and 
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antibiotics and incubated at 37 °C. Cultures have been successfully maintained with or 
without 5 % CO2 (reviewed by Visvesvara, 2002).    
In 1959 the first case of microsporidiosis in a human was documented 
(Matsubayashi et al. 1959).  Sporadic cases of microsporidiosis in humans were 
reported between 1959 and 1985 (Margileth et al. 1973; Marcus, Van der Walt & 
Burger, 1973; Sprague, 1974), however, it was not until the 1980’s that microsporidia 
gained attention as causing disease in man.  During the mid and late 1970’s increasing 
numbers of cases of severe diarrhea were reported in male homosexuals.  Although the 
etiologic agents in most of these cases were identified as Salmonellae, Shigellae, and 
Giardiae, in a portion of these cases with large-volume diarrhea the causative agent 
was not identified, and the patients did not respond to antibiotic therapy.  The 
syndrome in these cases was sometimes described as wasting disease (Wittner, 1999).  
In 1985 several reports described microsporidian parasites in acquired 
immunodeficiency syndrome (AIDS) patients suffering from chronic diarrhea 
(Dobbins, & Weinstein, 1985; Modigliani et al. 1985; Desportes et al. 1985).  Also in 
1985, Enterocytozoon beineusi, a new microsporidian parasite, was identified in AIDS 
patients (Desportes et al. 1985).  Consequently, microsporidiosis became recognized 
as a disease affecting the immunoincompetent.  Subsequently, human cases of 
microsporidiosis caused by E. cuniculi, E. intestinalis and E. hellem were increasingly 
reported (Wittner, 1999).  To date several other genera have been identified in human 
infections, including Nosema, Vittaforma, Brachiola, Trachipleistophora, and 
Pleistophora (Weiss, 2001).    
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Microsporidia are opportunistic pathogens most often associated with human 
immunodeficiency virus (HIV) infection and AIDS patients; however, cases have also 
been documented in immune suppressed individuals and occasionally in immune 
competent persons (Shadduck et al. 1990; Davis et al. 1990; Theng et al. 2001).  The 
most frequently identified microsporidia in humans are E. bieneusi, E. intestinalis, 
E. hellem, and E. cuniculi.  E. bieneusi and E. intestinalis can invade intestinal 
enterocytes resulting in chronic diarrhea in the infected patients.  In addition, 
E. intestinalis, as well as E. hellem and E. cuniculi, have been described in 
disseminated infections. In human patients, E. cuniculi is associated with encephalitis 
and hepatitis, while E. hellem infections are normally associated with 
keratoconjunctivitis, sinusitis, respiratory disease, and prostatic abscesses (Weiss, 
2001).     
Members of the genus Encephalitozoon are uninucleate and have an 
approximate spore size that ranges between 1.0 and 2.5 µm, with 4-9 coils of the polar 
filament arranged in a single row.   Spores are oval in shape and the exospore is 
uneven (Wasson & Peper, 2000).  All Encephalitozoon spp. replicate inside 
parasitophorous vacuoles within host cells and have a disporogonic life cycle 
producing two spores for every sporoblast.  E. intestinalis secretes a fibrillar network 
that gives the appearance that the vacuole is septate.  This feature can discriminate 
E. intestinalis from E. cuniculi and E. hellem, which are morphologically 
indistinguishable (Didier et al. 1991b). 
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The first reports of encephalitozoonoses in man were described as E. cuniculi 
based on the morphological characteristics of the parasite (Wittner, 1999).   However, 
morphology is only sufficient for genus identification, not species differentiation, as 
was shown by the characterization and subsequent naming of E. hellem (Didier et al. 
1991a).  In 1991, a new species was identified by immunological and protein analysis 
of isolates obtained from three AIDS patients suffering from keratoconjunctivitis.  
These isolates were distinguishable from E. cuniculi, Nosema corneum and Nosema 
algerae, but not from each other, by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) and immunoblot analysis.  As a result Didier and others 
proposed the name E. hellem for the isolates (Didier et al. 1991a).   
After 1991, the cause of subsequent cases of encephalitozoonosis in human 
patients was identified as E. hellem.   Doubt arose as to whether E. cuniculi was 
correctly identified in all cases of encephalitozoonosis described prior to 1991 and if 
E. cuniculi could infect man.  But in 1995 E. cuniculi infection in man was 
documented by molecular analysis.  However, question still remains as to whether E. 
cuniculi was actually the cause of all cases described prior to 1991, because the 
identification was based solely on morphology (Franzen & Muller, 1999). 
It is speculated that microsporidiosis in humans may be zoonotic.  
Microsporidia that infect humans have been reported in a number of different animals.  
E. bieneusi has been identified in pigs, cattle, cats, macaques, rabbits, and dogs 
(Mansfield et al. 1997; Breitenmoser et al. 1999; Dengjel et al. 2001).  E. cuniculi has 
been reported in rabbits, rodents, carnivores, and monkeys (Wasson & Peper, 2000).  
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Mammalian infections of E. intestinalis have been identified in dogs, donkeys, cows, 
goats, and pigs (Bornay-Llinares et al. 1998).  There is no direct evidence of animal to 
human transmission, but molecular analyses may serve as a helpful indicator of 
zoonoses.  Molecular markers can be used to analyze human and animal isolates to 
determine if they are genetically the same, thus implicating the ability to cross infect 
different hosts.   
Microsporidia infections have also been documented in different species of 
birds.  Reports based on morphologic identification of microsporidia in a number of 
avian hosts refer to the parasites as microsporidia, Encephalitozoon-like, or 
Encephalitozoon spp., but in these cases a parasite species was not identified.  The 
first described case identified Encephalitozoon in masked lovebirds (Agapornis 
personata) by histopathology and electron microscopy (Kemp & Kluge, 1975).  Since 
then, morphologic identification of the genus Encephalitozoon has been reported in 
the following bird species: peach faced lovebirds (Agapornis roseicollis) (Novilla, 
1978; Lowenstine & Petrak, 1980; Branstetter & Knipe, 1982; Norton & Prior, 1994), 
masked lovebirds (Agapornis personata) (Randall et al. 1986; Powell et al. 1989), 
Fischer’s lovebirds (Agapornis fischeri) (Randall et al. 1986), double yellow-headed 
Amazon parrots (Amazona ochrocephala) (Poonacha, William & Stamper, 1985; 
Canny et al. 1999), and an ostrich (Struthio camelus) (Gray, Puette & Latimer, 1998).   
Clinical infections were described in each of these cases except for the ostrich, which 
was not a clinical case but slaughtered for routine inspection.  In addition, many of the 
clinical cases involved young birds displaying signs such as anorexia, weakness, and 
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loose droppings, which presented approximately one month after purchase 
(Lowenstine et al. 1980; Poonacha et al. 1985; Randall et al. 1986).       
Increasingly, molecular tools are being used to supplement morphologic 
identification of microsporidia.  Comparison of the small subunit ribosomal RNA 
(SSUrRNA) gene has been widely used as a molecular marker for species 
identification.  The SSUrRNA gene is highly conserved among species and is useful 
for interspecies identification.  The internal transcribed spacer region (ITS) of the 
ribosomal RNA genes is less conserved and, therefore, is more variable between and 
within species and is a successful marker for strain typing (Adam et al. 2000).  These 
tools not only provide a means for species and strain differentiation, but may also be 
helpful as indicators of zoonoses.   
In 1995, Didier and colleagues identified differences in eight E. cuniculi 
isolates from 3 rabbits, 3 mice, and 2 dogs through molecular sequencing of the ITS 
region (Didier et al. 1995).  Differences in the ITS region were significant enough to 
group the isolates into three strains.  Sequence analysis revealed a 5’-GTTT-3’ 
sequence that was repeated 2, 3 or 4 times within the ITS sequence, depending on the 
isolate.  The isolates were grouped and typed as follows: strain type I, rabbit isolates, 
ITS sequence containing three 5’-GTTT-3’ repeats; strain type II, mouse isolates, ITS 
sequence containing 2 repeats; and strain type III, dog isolates, ITS sequence 
containing 4 repeats.  
Further sequence analyses of human and animal E. cuniculi isolates indicated 
strain type I and strain type III may be zoonotic. Strain type I is associated with rabbits 
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and has been identified from human isolates from Italy and Switzerland.  Strain type 
III has been identified from dogs and humans as well (Deplazes et al. 2000; Mathis et 
al. 1997).  An isolate of strain type III of domestic dogs was first identified from an 
AIDS patient in 1996 (Didier et al. 1996).  More recently, several studies have 
identified E. cuniculi strain type III by ITS sequence analysis from isolates obtained 
from additional dogs and from human patients worldwide (Snowden, Logan & Didier, 
1999; Weitzel et al. 2001; del Aguila et al. 2001; Tosoni et al. 2002). 
Similar heterogeneity exists among E. hellem isolates as demonstrated by ITS 
and SSUrRNA nucleotide sequencing (Mathis et al. 1999; Xiao et al. 2001).  Between 
1993 and 1998, identical ITS regions were published for 4 E. hellem isolates 
originating from the USA and Germany (Vossbrinck et al. 1993; Katiyar et al. 1994; 
Franzen et al. 1998).  However, in 1999 2 additional genotypes were described by 
Mathis et al. after sequencing the ITS regions of E. hellem isolates from Swiss and 
Tanzanian HIV patients (Mathis et al. 1999).  The isolates were referenced against the 
previously known ITS sequences, classified as genotype I.   The ITS sequences from 2 
of the Swiss patient isolates and the Tanzanian patient isolate were identical, but 
differed from genotype I by 5 base pair substitutions, 3 single nucleotide deletions, 
and an extra poly T stretch at the 3’ end, and was therefore classified as genotype II.  
One of the substitutions was a G for an A, resulting in a tetrameric 5’-GTTT-3’ in 
place of  5’-ATTT-3’.  The last sequence, also a Swiss isolate, contained this 
particular base pair substitution but with an additional 5’-GTTT-3’ repeat, and was 
classified as genotype type III.  Genotype III was identical to genotype II except for 
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this additional repeat.  In summary, 2 Swiss and 1 Tanzanian isolate were genotype 
type II, and 1 Swiss isolate was genotype III based on GTTT repeats found within ITS 
sequences, similar to the genotypes of E. cuniculi (Mathis et al. 1999).   
Partial sequencing of the SSUrRNA gene and/or ITS regions identified 
E. hellem in different bird species.  In 1997, molecular analysis using polymerase 
chain reaction (PCR) and Southern blotting identified E. hellem as the species 
responsible for infection of budgerigars (Black et al. 1997).  Partial sequencing of the 
SSUrRNA gene also identified E. hellem in two eclectus parrots (Pulparampil et al. 
1998), an ostrich (Snowden & Logan, 1999), and a clinically normal peach faced 
lovebird (Snowden, Logan & Phalen, 2000).  The ITS region was used as a molecular 
marker for identification of E. hellem in a wild yellow streaked lory, which was the 
first case to identify E. hellem in a wild caught bird (Suter et al. 1998). E. hellem was 
also identified in hummingbirds by sequencing portions of the SSUrRNA and the ITS 
region (Snowden, Daft & Nordhausen, 2001).  The sequencing results of these various 
isolates showed 99% to 100% identity with E. hellem human isolate sequences.  
Analysis of the ITS regions from different bird isolates, including hummingbird 
(Snowden et al. 2001), a peach faced lovebird (Snowden et al. 2000), and a yellow 
streaked lory (Suter et al. 1998), characterized them as genotype I.   
The gene coding for the polar tubule protein (PTP) has also been sequenced 
from E. hellem isolates as a tool for molecular genotyping.  In a 2001 study of 24 
isolates, the ITS region and the SSUrRNA and PTP genes were sequenced and 
compared (Xiao et al. 2001).  The PTP sequences showed the highest resolution, 
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grouping the isolates into 4 genotypes.  The differences in these sequences were due to 
a 60 base pair repeat that was repeated 6, 7, 8, or 3 times for genotypes 1A, 1B, 2A, or 
2B, respectively.  The PTP genotype 2B sequence also included five 66 base pair 
repeats and an 18 base pair insert upstream of the repeat region (Xiao et al. 2001).   
Interestingly, in this same study the ITS region had less variability than the 
SSUrRNA genes sequenced.  Based on ITS region and SSUrRNA gene sequence 
analysis, the isolates had 2 and 3 genotypes, respectively.  The isolates were obtained 
from biopsy, bronchoalveolar (BAL), sputum, and urine samples from 20 human 
patients worldwide including the USA (11), Puerto Rico (1), Italy (10), Switzerland 
(1), and Spain (1).  Sequence analysis of the ITS region showed that all the isolates, 
except for the Switzerland urine isolate, were identical to genotype 1 described 
previously by Mathis et al. (1999),  and the Switzerland isolate was similar,  but not 
identical,  to genotypes 2 and 3 reported by Mathis et al. (1999). Sample site, i.e., 
urine, sputum, etc., had no apparent correlation with the obtained genotypes (Xiao et 
al. 2001).  Further molecular and epidemiologic studies are needed to assess the 
significance of these results, and isolates obtained from birds should be included.  
Currently ITS genotype 1 is the predominant genotype of human and bird isolates (del 
Aguila et al. 2001; Xiao et al. 2001).  
Based on an increasing collection of data, it is probable that birds are the 
natural hosts of E. hellem. As noted  above, the organisms have been identified in a 
number of different bird species, including both wild birds (Suter et al. 1998) as well 
as pet birds (Barton, Phalen & Snowden et al. 2000).  E. hellem infections have been 
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described in both symptomatic and asymptomatic birds.  In addition, concurrent 
bacterial (Powell et al. 1989; Black et al. 1997) and viral infections (Pulparampil et al. 
1998) were also documented in clinically ill birds suggesting that microsporidia may 
not otherwise cause disease in birds, but rather that birds may be asymptomatic 
carriers.  Although the majority of cases in which E. hellem was identified in birds 
involved psittacine birds, the identification of E. hellem from an ostrich, gouldian 
finch and hummingbirds shows that E. hellem infections are not restricted to members 
of the parrot family.  The higher detection of E. hellem in psittacine birds is most 
likely attributed to the popularity of psittacine birds as pets, which are more likely to 
receive veterinary attention when ill.   
Molecular comparisons of SSUrRNA and ITS sequences from human and 
avian isolates show greater than 99 % identity.  Thus, it has been suggested that E. 
hellem may be a zoonotic parasite and that birds may be the natural host of E. hellem 
(Black et al. 1997; Pulparampil et al. 1998; Canny et al. 1999; Snowden & Logan, 
1999).  However, further evidence is needed to validate this hypothesis, so the current 
study was undertaken using molecular and in vitro growth studies to address this 
question. Previously, in vitro growth comparisons have been performed with the 
mosquito microsporidian parasite N. algerae (Trammer et al. 1999).  The first studies 
were performed to determine if N. algerae could infect mammalian cells and replicate 
at mammalian temperatures in order to predict the ability of these microsporidia to 
infect humans (Undeen, 1975).  A recent study by Trammer et al. (1999) comparing 
the in vitro infectivity and replication of N. algerae in mammalian cells at 31 °C and 
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38 °C showed that it took longer before infected cells could be detected and that a 
lower number of spores were produced at 38°C.  That study indicates that in vitro 
models can be used to show the preferred host conditions of these parasites, because 
deviations from their natural host conditions can result in delayed replication and a 
decrease in the number of spores being produced.    
In vitro growth comparisons were performed in the current study using 2 
different models, 1 simulating mammalian host conditions and 1 simulating avian host 
conditions, in order to compare the growth of 2 different isolates of E. hellem.    An 
E. hellem isolate cultured from a bird (Snowden et al. 2000) and an isolate cultured  
from a human infection (Didier et al. 1991a) were compared to each other and to an 
isolate of E. cuniculi (rabbit isolate, gift of John Shadduck), a well-characterized 
mammalian parasite, which served as a control.  
Molecular comparisons of the bird and human E. hellem isolates and  
E. cuniculi were performed in this study.  A gene coding for a metallo-aminopeptidase 
was chosen as an additional molecular marker to evaluate homology between the 2  
E. hellem isolates.  This gene is of particular interest because previous studies have 
indicated that inhibition of aminopeptidases may serve as an effective treatment of 
microsporidiosis.  The sequence data obtained from this study will be valuable in 
future drug design and treatment of microsporidiosis.   
The gene coding for a zinc metallo-aminopeptidase was sequenced from bird 
and human isolates of E. hellem and a rabbit isolate of E. cuniculi.  The obtained 
sequences were aligned and compared for percent homology.  Furthermore, the 
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obtained E. cuniculi aminopeptidase sequence was also compared to the sequence 
from a different isolate of E. cuniculi in the GenBank database (GenBank accession 
no. CAA06646).  Inter- and intragenic variation was evaluated among the isolates.   
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CHAPTER II 
MOLECULAR COMPARISONS 
Introduction 
Microsporidia are spore forming intracellular parasites found worldwide with a 
wide host range (Mathis, 2000).  These parasites are opportunistic pathogens known to 
cause disease in immunocompromised individuals, especially in human 
immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) 
patients (Wittner, 1999).  However, occasional cases of microsporidiosis in 
immunocompetent individuals have been documented (Matsubayashi et al. 1959; 
Ashton & Wirasinha, 1973; Pinnolis et al. 1981; Davis et al. 1990; Theng et al. 
2001;).  Clinical syndromes associated with human microsporidiosis include intestinal, 
ocular, pulmonary, renal, urinary, cerebral and disseminated disease (Didier et al. 
1991a; Weber et al. 1993; Kotler & Orenstein, 1998).  Commonly identified 
microsporidia in human patients are E. intestinalis, E. cuniculi, E. hellem, and 
Enterocytozoon bieneusi.  Intestinal disease is the most common syndrome caused by 
microsporidia; clinical symptoms include abdominal pain, chronic diarrhea, and 
weight loss. E. bieneusi followed by E. intestinalis are the most prevalent 
microsporidia causing intestinal disease in man (Kotler & Orenstein, 1998).     
Albendazole is the most commonly administered drug used in the treatment of 
intestinal and disseminated microsporidiosis (Costa & Weiss, 2000).  However, the 
efficacy of this drug is limited.  Albendazole therapy for the treatment of 
microsporidiosis caused by E. bieneusi has had poor results.  Clinical improvement, 
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indicated by a decrease in the number of bowel movements, was noted in a few cases 
by patients receiving albendazole therapy. However, parasite clearance was not 
observed.  Consequently, relapse occurred when therapy was discontinued.  
Furthermore, in many cases neither clinical nor microbiological improvement was 
observed (Brasil et al. 1998; Georges et al. 1998; Leder et al. 1998; Goetz et al. 2001).   
A retrospective study by Leder et al. (1998) reviewed the clinical features and 
therapy of 42 HIV patients with intestinal microsporidiosis.  Patients displayed clinical 
symptoms such as weight loss, diarrhea, abdominal pain, anorexia, and nausea.  
Patients reported between 1-20 bowel movements per day (average of 4.5) and a 
decrease in body weight ranging from 2.9 to 48.8 % of initial body weight (average 19 
%).  All of these patients were infected with either E. bieneusi (n = 29) or E. 
intestinalis (n = 13).  Of the E. bieneusi infected patients, 1 patient had a positive 
nasopharyngeal aspirate (NPA) while NPA and sputum aspirates from 5 other patients 
were negative.  Sputum and/or bronchial washing, nasal secretions, and NPA samples 
were obtained from 11 of the E. intestinalis infected patients, resulting in evidence of 
dissemination in 8 of these patients.   Metronidazole (400 mg 3 times daily for 1-2 
weeks) was administered to 9 of the E. bieneusi infected patients and 1 E. intestinalis 
infected patient.  Albendazole (400 mg twice daily for 1-2 months) was used in the 
treatment of 8 of the E. intestinalis infected patients and 5 of the E. bieneusi infected 
patients.  Five of the E. bieneusi infected patients received metronidazole followed by 
albendazole.  None of the E. bieneusi treated patients showed clinical improvement.  
Eight patients reported a decrease in the number of bowel movements per day, 
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however, in all cases relapse occurred between 6-8 weeks after therapy was 
discontinued.  E. intestinalis infected patients responded to albendazole therapy with 
improvement in diarrhea and/or sinusitis.  Clinical relapse was not documented in any 
of these cases; however, post-treatment samples were not obtained to evaluate 
parasitic clearance.  There was no improvement observed in the E. intestinalis infected 
patient treated with metronidazole (Leder et al. 1998).  
Albendazole treatment of Encephalitozoon spp. infected patients has had better 
results in reducing clinical symptoms and parasite clearance.  However, in some cases 
complete parasite clearance was not observed and relapses occurred (Molina et al. 
1995; Dore et al. 1995; Gunnarsson et al. 1995; Moss et al. 1997; Fournier et al. 
2000). Molina et al. (1995) described 5 cases of disseminated microsporidiosis due to 
E. intestinalis.  Patients exhibited chronic diarrhea reporting 3-20 bowel movements 
per day; other symptoms included sinusitis and bronchitis.  Patients received 400 mg 
of albendazole twice daily for between 8-25 days.  Clinical improvement was 
observed in all patients and parasite clearance was observed in the stools of all 
patients.  However, spores were not cleared from the urine of 2 patients, and spores 
were detected in stool during follow up visits.  Diarrhea recurred in these 2 patients 
(Molina et al. 1995).  Patients infected with E. cuniculi receiving albendazole therapy 
have also demonstrated clinical improvement, however, parasite clearance was not 
always observed and clinical relapse was also documented (Fournier et al. 2000).  
Albendazole treatment of dual infection due to E. hellem and Vittaforma corneae in an 
AIDS patient complaining of respiratory, abdominal, and urogenital discomfort 
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resulted in clinical improvement and parasite clearance from respiratory secretions, 
but not urine (Deplazes et al. 1998).    
A more effective drug therapy against human microsporidiosis remains to be 
developed.  Identifying enzymes involved in parasitic life cycles is an important step 
in targeting specific enzymes for potential drug development (McKerrow, 1999).  
Parasitic proteases have been identified in a variety of protozoa including members of 
the genera Plasmodium, Trypanosoma, Cryptosporidium, Giardia, Entamoeba, 
Trichomonas, and Leishmania (reviewed by Klemba & Goldberg, 2002).  In addition, 
proteases from these parasites have been investigated at molecular and cellular levels 
and recognized in host cell invasion, excystation, metabolism, and cytoadherance, and 
also as virulence factors (Klemba & Goldberg, 2002).    
Aminopeptidases are a group of proteases that cleave amino acid residues from 
the N-terminus of peptide substrates and proteins.  Aminopeptidases have been 
identified in a number of different organisms and are involved in essential physiologic 
functions (Taylor, 1993).  Aminopeptidases of opportunistic pathogens have been 
described in facilitating the attachment and invasion of bacteria to host cells, nutrient 
uptake, dissemination of infection (Miyoshi & Shinoda, 2000), and Cryptosporidium 
parvum excystation, a critical life cycle event (Okhuysen et al. 1996).   
Inhibitors of parasitic aminopeptidases have been evaluated as potential 
chemotherapeutic agents of parasitic diseases (Okhuysen et al. 1996; Day & Chen, 
1998).   Most aminopeptidases are inhibited by bestatin and/or its analogs, and 
metallopeptidases (aminopeptidases that require at least one metal ion for catalytic 
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activity) are additionally inhibited by chelating agents such as ethylenediamine 
tetraacetate (EDTA) (Taylor, 1993).  Aminopeptidase activity of enzyme extracts of 
Leishmania spp. and Toxoplasma gondii are strongly inhibited by bestatin, EDTA and 
1,10-phenanthroline (Berthonneau et al. 2000; Morty & Morehead, 2002). The 
aminopeptidase inhibitors bestatin and nitrobestatin successfully inhibited 
aminopeptidase activity and parasite growth of Plasmodium chabaudi chabaudi and 
Plasmodium falciparum in vitro (Nankya-Kitaka et al. 1998).   Also, an arginine 
aminopeptidase of C. parvum oocysts was successfully inhibited in vitro (Okhuysen et 
al. 1994).    This aminopeptidase exhibited highest activity during excystation in vitro, 
and enzymatic activity and excystation were successfully inhibited with the 
aminopeptidase inhibitor amastatin, EDTA, or 1,10-phenanthroline (Okhuysen et al. 
1994; Okhuysen et al. 1996).   
Aminopeptidase activity of E. intestinalis, E. cuniculi, E. hellem, and 
V. cornea has been characterized using a variety of fluorometric substrates (Millership 
et al. 2001; Millership et al. 2002b). The aminopeptidase described showed highest 
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activity against the substrate leucine and demonstrated maximal activity at 37 °C and 
pH 7.2.  The aminopeptidase inhibitors, bestatin and nitrobestatin, and the chelating 
agent, 1,10-phenanthroline, successfully inhibited the enzymes of all 3 microsporidia 
(Millership et al. 2002a).  Visualization of aminopeptidase activity using L-Met-7-
amino-4-trifluoromethyl coumarin (L-Met-AFC) substrate was associated with 
parasites in the host cell cytoplasm and the microsporidial polar tubule.  The 
molecular masses of the enzymes, estimated using fluorogenic analysis with L-Met-
AFC on polyacrylamide gels, were 70, 74, 72, and 78 kDa for E. intestinalis, E. 
cuniculi, E. hellem, and V. corneae, respectively (Millership et al. 2002a).  
Aminopeptidase inhibitors have been evaluated both in vitro and in vivo as 
antimicrosporidial therapies.  In vitro studies using bestatin, amastatin, and 
nitrobestatin significantly reduced E. cuniculi replication without significant host cell 
toxicity (Millership et al. 2001).  In vivo experiments showed that E. cuniculi infected 
athymic mice showed prolonged survival when treated with bestatin (Millership et al. 
2001).  
In this work, the cloning, sequencing, and molecular characterization of an 
aminopeptidase gene from 3 isolates of Encephalitozoon are described.   
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Material and Methods 
Encephalitozoon Isolates 
 The bird isolate of E. hellem was isolated from droppings of a love bird 
(Agapornis roseicollis) (Snowden et al. 2000).  The human E. hellem isolate was from 
a human AIDS patient suffering from keratoconjunctivitis (Didier et al. 1991a).  The 
E. cuniculi isolate was originally from a rabbit (Oryctolagus cuniculi) (Shadduck, 
1969).  All isolates were kindly provided by Dr. Karen Snowden, Texas A&M 
University.   
 
Spore Collection 
Cryopreserved pellets of the bird and human E. hellem isolates and E. cuniculi 
were thawed and maintained in culture in 75 cm2 flasks using RK-13 rabbit kidney 
cells (ATCC no. CCL-37) in Dulbecco’s Modified Eagle Medium (DMEM) (Sigma, 
St. Loius, MO) supplemented with L-glutamine (2 mM), 10 % heat inactivated fetal 
bovine serum (FBS) and antibiotic/antimycotic (Gibco BRL, Grand Island, NY) at 37 
°C and a humidified 5 % CO2 in air atmosphere.  Spores were collected periodically 
from the culture supernatants.  Spores were pelleted by centrifugation at 800 g for 20 
min and washed with sterile tap H2O to lyse host cells.  The final spore pellets were 
resuspended in 5 ml DMEM.  Samples of the resuspended spore pellets were 
quantified on a hemocytometer, and the spore suspensions were adjusted to 1.0 x 109 
spores/ml and stored at 4 °C until used. Two aliquots of 1.0 x 109 spores of each 
isolate described above, E. cuniculi and E. hellem (human and bird), were placed in 15 
 
 23
ml conical tubes and washed twice in phosphate-buffered saline (PBS).  The final 
spore pellets were transferred to 2 ml bead-beater tubes and centrifuged at 800 g for 5 
min and the remaining supernatant discarded.  One tube of spores for each isolate was 
used for total RNA isolation and the other frozen at -20 °C for later isolation of 
genomic DNA (gDNA).        
 
Total RNA Isolation 
  The washed spore pellets, in each 2 ml microtube, were resuspended in 750 
µl lysis/binding buffer (RNAqueous, Ambion, Austin, TX) and approximately 600 µl 
0.5 mm zirconia/silica beads (Biospec Products, Bartlesville, OK) was added to each 
tube.  Spores were beaten at 500 rpm for 30 s in a Mini-bead beater (Biospec Products, 
Bartlesville, OK), then cooled on ice for 1 min.  This was repeated 4 times.  The tubes 
were centrifuged for 2 min at 5600 g and the supernatants collected.  An additional 
600 µl of lysis buffer was added to each tube and the above cycle repeated.  The tubes 
were centrifuged again for 2 min at 5600 g and the supernatants collected.  The 
supernatants from each isolate were pooled and total RNA was purified from each 
according to the RNAqueous kit protocol (Ambion). 
 
Genomic DNA Isolation 
Genomic DNA was isolated from the frozen spore samples of E. cuniculi and 
bird and human E. hellem isolates described above.  The samples were thawed at 37 
°C and approximately 600 µl 0.5 mm zirconia/silica beads (Biospec Products) and 180 
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µl lysis solution (GENE Elute, Sigma, St. Louis, MO) were added to pellets. Spores 
were bead blasted as described above.  Each supernatant was treated separately with 
Proteinase K and DNA eluted following manufacturer’s instructions (GENE Elute). 
 
cDNA First Strand Synthesis 
E. hellem bird and human isolate and E. cuniculi isolate cDNAs were prepared 
from the total RNA described above (SMARTTMRACE cDNA amplification kit; 
Clontech Laboratories, Palo Alto, CA).  First strand 3’ cDNA was prepared by mixing 
3 µl RNA sample and 1 µl 3’-CDS primer, and first strand 5’ cDNA was prepared by 
mixing 3 µl RNA sample, 1 µl 5’-CDS primer, and 1 µl SMART II oligo.  Sterile H2O 
was added to each reaction to a final volume of 5 µl.  The reaction mixes were 
incubated at 70 oC for 2 min in a heated block and briefly cooled on ice for an 
additional 2 min.   Next, to each tube 2 µl 5X First-strand buffer, 1 µl DTT (20 mM), 1 
µl dNTP Mix (10 mM), and 1 µl MMLV reverse transcriptase (200 units/µl) were 
added and the reactions mixed.  The reactions were incubated for 1.5 h at 42 oC in an 
air incubator.  Following this step, 20 µl of Tricine-EDTA buffer was added to each 
tube and the tubes were heated at 72 oC in a heated block for 7 min.  Samples were 
stored at -20 oC until used.                   
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Table 2.1. Oligonucleotide primers used for amplification and sequencing reactions.  Primers 
1 and 2 were used for homology PCR with gDNA from both E. hellem and E. cuniculi.  
Primers 3 -14 are E. hellem specific primers and Primers 15-26 are specific for E. cuniculi.   
 
Primer 
Number 
Primer Name Sequence 5’ – 3’ Direction Position 
1 ZAPFEc CAN CAY TTY GAR CCN CAN GA Forward 436-455 
2 ZAPREc CCA NAR RTC RTC CCA CCA Reverse 1019-1036 
3 ZAPEhF GCG GGA GGA GTA TGG AGA CAG G Forward 576-597 
4 ZAPEhR CTG TCT CCA TAC TCC TTC CGC AGC G Reverse 572-596 
5 ZAPEh5F GCG ATG GAG AAC TGG Forward 874-888 
6 ZAPEhA GAG CAA GCA TCA TCA GG Forward 1256-1272 
7 ZAPEh3R300 ATT CTT CTG CAC CAT CG Reverse 2378-2394 
8 ZAPEh5F1090 GCA TGT GGA TTG TGC C Forward 1526-1541 
9 ZAPEh5’F GTA TGA AGT GGA TTG AAT TG Forward -2-18 
10 ZAPEh3’R CAG AGG AGC AGA GTC CTG C Reverse 2575-2593 
11 ZAP350F GGA TAC ATT GTG GGA GAG Forward 352-369 
12 ZAP690R GAC TTG CTC CAG Reverse 681-692 
13 ZAP1857F GAG AAG CTG ATG CGG Forward 1852-1866 
14 ZAP2169R CCC CAA TCA GGT GCT C Reverse 2149-2163 
15 ZAPEC5PF AAA TGA GGT GGA TTA AAG TAA TGG C Forward -2-23 
16 ZAPEC3PR TTA CTT CTC AGC CTC CGG C Reverse 2576-2595 
17 ZAPEC5PFN TTG AGA GGT ATG TCG GCG AG Forward 1288-1269 
18 ZAPEC3PRN TGC ACA GAC ACA ACA GGA TAC C Reverse 1431-1452 
19 ZAPEC5PFN2 AGG GCT TCT GCC CAT GA Forward 25-41 
20 ZAP ECR1900 ATC TCA AGC TCC TTG GC Reverse 211-227 
21 ZAPEC3PRN2 AGA AGC CCA CGA AGG ACC Reverse 2560-2577 
22 ZAPEC3PRN3 AGA AGC CCA CGA AGG ACC TCC TCT C Reverse 2553-2577 
23 ZAPEc5PN4 CCG GCG GTA CAT CAA GGA GCA C Forward 1309-1330 
24 ZAPECF1800 TCG TAC CAT GTT GCT CG Forward 1816-1832 
25 ZAPEcS1-R TCG CCT TCA TAT CGG Reverse 489-503 
26 ZAPECS2F TCG ACA GCA TCA GCT AC Forward 1817-1833 
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Homology PCR 
Degenerate primers, Primers 1 and 2 (Table 2.1; Figure 2.1 on p. 36), were 
designed from conserved regions of the available aminopeptidase sequence of E. 
cuniculi (GenBank accession no. CAA06646) (Fig. 2.1) for use in homology PCR.  
Advantage 2 PCR Enzyme System (Clontech Laboratories, Inc., Palo Alto, CA) 
reagents were used in all PCR reactions, which were carried out in a PCR Express or 
Sprint thermocycler (Hybaid, Ashford, Middlesex, TW15 1XB).  [The sequences and 
location of all primers described throughout the text can be found in Table 2.1.] 
The accuracy of Primers 1 and 2 was tested in a PCR reaction containing 1 µl (50-
100 ng) E. cuniculi gDNA with 15.5 µl dH2O, 2.5 µl 10X cDNA PCR Reaction 
buffer, 0.5 µl dNTP Mix (10 mM), 0.5µl Advantage 2 Polymerase Mix (50X), 2.5 µl 
Primer 1 (0.1 µM), and 2.5 µl Primer 2 (0.1 µM) performed under the following 
cycling parameters: initial denaturation, 94 oC for 1 min; 40 cycles of denaturation at 
94 oC for 45 s, annealing at 50 oC for 30 s, end extension at 72 oC for 1 min 30 s; a 
final extension at 72 oC for 10 min, and 4 oC hold.  The PCR product was visualized 
by separation on a 1 % high melt agarose gel (W/V) in TBE buffer (45 mM Tris, 45 
mM borate, 1mM EDTA, pH 8.0) followed by ethidium bromide staining and UV 
transillumination.   
Multiple amplicons were present, so the remainder of the PCR product was 
separated on a 1 % low melt agarose gel (W/V) in TAE buffer (45 mM Tris, 45 mM 
acetic acid, 1 mM EDTA, pH 8.0) and a 600 bp band cut from the gel. 
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The gel slice was heated at 72 oC for 10 min and ligated into plasmid vector 
PCRTM II and competent Escherichia coli transformed (TOPO-TA Cloning Kit, 
Invitrogen, San Diego, CA).  Plasmid DNA from each color-selected clone was 
purified from overnight Luria Broth (LB) cultures by a modified alkaline lysis 
procedure (QIAprep Spin Miniprep Kit; Qiagen, Valencia, CA). Two clones were 
selected and sequencing was carried out in either an ABI PRISM Model 373A or ABA 
Model 377 automated sequencer with Version 1.2 or Version 2.1 software, 
respectively (Gene Technologies Laboratory, Institute of Developmental and 
Molecular Biology, Department of Biology, Texas A&M University, College Station, 
TX).  The cloned inserts were sequenced using M13 F and M13 R primers.  These 
primer sites are located within the plasmid vector flanking the PCR insert.  The 
obtained nucleotide sequences were then subjected to BLAST searches (Altschul et al. 
1992) by the GenBank database (National Center for Biotechnology Information, 
National Institute of Health).   
The same PCR reaction mix and cycling parameters as described above were 
performed again except 1 µl (50-100 ng) E. hellem (bird) gDNA was used in lieu of 
E.  cuniculi gDNA.  A single 600 bp amplicon was obtained and 4 µl of PCR product 
was ligated into a plasmid vector as described above.  Plasmid DNA was isolated and 
2 clones sequenced using primers M13 F and M13 R.  The obtained nucleotide 
sequences were also subjected to BLAST searches.  Specific E. hellem primers, Primer 
3 and Primer 4, were designed from the obtained sequence for use in RACE reactions 
(Table 2.1 and Fig. 2.2 on p. 36).  
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Amplification of Aminopeptidase Genes from cDNA  
3’RACE E. hellem (bird)  
The 3’ RACE PCR reaction was performed using 1.2 µl of a 1:2 dilution of 
E. hellem (bird) 3’ first strand cDNA and 16.8 µl dH2O, 2.5 µl 10X cDNA PCR 
Reaction buffer, 0.5 µl dNTP Mix (10 mM), 0.5 µl Advantage 2 Polymerase Mix 
(50X), 2.5 µl Primer 3 (0.1 µM), and 2.5 µl of 10X Universal Primer Mix (UPM; 
primer complementary to the linker added to the 3’ end of the 3’ cDNA during 
synthesis) under the following cycling parameters: 40 cycles of denaturation at 94 oC 
for 5 s, annealing at 68 oC for 10 s, end extension at 72 oC for 3 min; final extension at 
72 oC for 10 min, and 4 oC hold.  A 2000 bp amplicon was ligated and transformed as 
described above.  Plasmid DNA was extracted and selected clones sequenced with 
M13 F, M13 R, and Primers 5, 6, 7, 8, and 12 (Table 2.1).   
5’RACE E. hellem (bird) 
A primary 5’RACE PCR reaction was performed as the 3’ RACE PCR reaction 
except 5’ first strand cDNA replaced 3’ first strand cDNA, and Primer 2 was used in 
place of Primer 3.  A nested PCR followed this reaction using 1.0 µl of a 1:100 
dilution of the primary PCR product and 17.0 µl dH2O, 2.5 µl 10X cDNA PCR 
Reaction buffer, 0.5 µl dNTP Mix (10 mM), 0.5 µl Advantage 2 Polymerase Mix 
(50X), 2.5 µl Primer 4 (0.1 µM), and 2.5 µl of 10X Nested Universal Primer (NUP; 
nested primer complementary to the linker added to the 3’ end of the 3’ cDNA during 
synthesis).  The cycling parameters were as previously described for 25 cycles.  An 
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approximately 600 bp band was excised from a 1 % low melt agarose gel (W/V) in 
TAE and subsequently ligated as previously described.  Plasmid DNA was extracted 
and selected clones sequenced with primers M13 F and M13 R.            
 The obtained nucleotide sequences from the 3’ and 5’ RACE reactions were 
aligned using SEQUENCHER (Gene Codes Corp, Ann Arbor, MI) and used to design 
5’- and 3’-end specific primers, Primers 9 and 10 (Table 2.1), for amplifying the 
E. hellem (human) aminopeptidase gene.     
Amplification Amiopeptidase genes from E. hellem (human) cDNA 
Two PCR reactions were performed to obtain overlapping fragments 
encompassing the entire E. hellem (human) aminopeptidase gene.  The first PCR 
reaction was performed using 2.5 µl of E. hellem (human) 3’ first strand cDNA and 
15.5 µl dH2O, 2.5 µl 10X cDNA PCR Reaction buffer, 0.5 µl dNTP Mix (10 mM), 0.5 
µl Advantage 2 Polymerase Mix (50X), 2.5 µl Primer 2 (0.1 µM), and 2.5 µl of Primer 
9 (0.1 µM ) under the following cycling parameters: 25 cycles of denaturation at 94 oC 
for 5 s, annealing at 68 oC for 10 s, and extension at 72 oC for 4 min; final extension at 
72 oC for 10 min, and 4 oC hold.  The PCR product was purified (QIAgen PCR 
Purification Kit, QIAGEN) and a 1000 bp amplicon was ligated and transformed as 
described above.  Plasmid DNA was extracted and selected clones sequenced with 
Primers 3, 12 and M13 F and M13 R.  The second PCR reaction contained 2.5 µl of 
E.  hellem (human) 5’ first strand cDNA and 15.5 µl dH2O, 2.5 µl 10X cDNA PCR 
Reaction buffer, 0.5 µl dNTP Mix (10 mM), 0.5 µl Advantage 2 Polymerase Mix 
(50X), 2.5 µl Primer 3 (0.1 µM), and 2.5 µl of Primer 10 (0.1 µM) under the following 
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cycling parameters: 25 cycles of denaturation at 94 oC for 5 s, annealing at 68 oC for 
10 s, and extension at 72 oC for 4 min; final extension at 72 oC for 10 min, and 4 oC 
hold.  The PCR product was purified and a 2000 bp amplicon was ligated and 
transformed as described above.  Plasmid DNA was extracted and selected clones 
sequenced with M13 F, M13 R and Primers, 5, 6, 8, and 10 (Table 2.1).   
 
Amplification of Aminopeptidase Genes from gDNA             
E. hellem bird and human isolates 
The full length aminopeptidase gene was directly amplified from E. hellem 
bird and human gDNA.  The 25 µl reaction mixes contained 17.0 µl dH2O, 2.5 µl 10X 
cDNA PCR Reaction buffer, 0.5 µl dNTP Mix (10 mM), 0.5 µl Advantage 2 
Polymerase Mix (50X), 2.5 µl Primer 9 (0.1 µM), and 2.5 µl of Primer 10 (0.1 µM), 
and either 1 µl (50-100 ng) E. hellem (bird) or E. hellem (human) gDNA.  Touch 
down PCR was performed as follows: initial denaturation at 94 oC for 2 min; 20 cycles 
of 94 oC for 10 s, 65 oC for 10 s, 72 oC for 3 min; 20 cycles of denaturation at 94 oC 
for 10 s, annealing at 55 oC for 10 s, and extension at 72 oC for 3 min; final extension 
for 10 min at 72 oC, and 4 oC hold.  The amplicons were visualized by ethidium 
bromide stained agarose gels as described above.  Repeated attempts to clone the 
products for sequencing were not successful.  PCR products from several reactions for 
each E. hellem isolate were pooled and purified (QIAgen PCR Purification Kit, 
QIAGEN).  The purified product was visualized on an agarose gel and quantitated.  
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The purified PCR products were directly sequenced with Primers 3, 5, 6, 8, 10, 11, 12, 
13 and 14.   
E. cuniculi  
The targeted aminopeptidase gene of E. cuniculi was amplified from gDNA 
using a nested PCR protocol, since a single usable band was not obtained in PCR 
reactions with 5’ and 3’ primers.  Specific primers were designed from E. cuniculi 
aminopeptidase nucleotide sequence available in the GenBank database (accession no. 
AJ005644) and used to generate overlapping fragments that were subsequently cloned 
and sequenced.   
The primary PCR was performed using 1.0 µl (50-100 ng) of E. cuniculi 
gDNA, 15.5 µl dH2O, 2.5 µl 10X cDNA PCR Reaction buffer, 0.5 µl dNTP Mix (10 
mM), 0.5 µl Advantage 2 Polymerase Mix (50X), 2.5 µl Primer 15 (0.1 µM), and 2.5 
µl of Primer 16 (0.1 µM) under the following cycling parameters: initial denaturation 
at 94 oC for 3 min; 30 cycles of denaturation at 94 oC for 45 s, annealing at 62 oC for 
30 s, and extension at 72 oC for 3 min; final extension at 72 oC for 10 min and 4 oC 
hold.   
The nested PCR reaction for the 5’ end of the gene was performed using 2.0 µl 
of primary PCR product, 14.5 µl dH2O, 2.5 µl 10X cDNA PCR Reaction buffer, 0.5 µl 
dNTP Mix (10 mM), 0.5 µl Advantage 2 Polymerase Mix (50X), 2.5 µl Primer 18 (0.1 
µM), and 2.5 µl of Primer 19 under the following cycling parameters: initial 
denaturation at 94 oC for 3 min; 40 cycles of denaturation at 94 oC for 45 s, annealing 
at 62 oC for 30 s, and extension at 72 oC for 2 min; final extension at 72 oC for 10 and 4 
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oC hold.  The PCR products were purified (QIAgen PCR Purification Kit, QIAGEN) 
and the final product was visualized on a 1% agarose gel (W/V) in TBE buffer.  
Approximately 100 ng PCR product was sequenced with Primer 5.  In addition, 4 µl of 
the purified PCR product was cloned and sequenced using M13 R and Primers 19, and 
20.      
The 3’ end was generated by PCR using 2.0 µl of a 1:5 dilution of E. cuniculi 
gDNA, 15.5 µl dH2O, 2.5 µl 10X cDNA PCR Reaction buffer, 0.5 µl dNTP Mix (10 
mM), 0.5 µl Advantage 2 Polymerase Mix (50X), 2.5 µl Primer 22 and 2.5 µl of 
Primer 23 (0.1 µM ) under the following cycling parameters: initial denaturation of 94 
oC for 3 min; 40 cycles of 94 oC for 45 s, and 72 oC for 2 min; final extension at 72 oC 
for 10 and 4 oC hold.  The resulting amplicon was cloned and sequenced with Primers 
21, 23, 25 and 26.  
 
Sequence Alignment Comparisons 
The nucleotide and predicted amino acid sequences of the zinc metallo-
aminopeptidase (ZAP) genes obtained in the study were aligned and compared using 
ClustalW, EMBL-EMBI, European Bioinformatics Institute, http:// 
www.ebi.ac.uk/clustalw).   The gDNA and cDNA sequences for each E. hellem isolate 
were aligned and compared; the gDNA and cDNA sequences were also compared 
between the bird and human isolates.  The predicted amino acid sequences of both 
E. hellem isolates obtained from cDNA were aligned and compared with the amino 
acid sequence predicted from the E. cuniculi gDNA sequence. In addition, the E. 
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cuniculi gDNA sequence was aligned and compared to the E. cuniculi ZAP sequence 
in GenBank (accession no. CAA06446).    
 
Protein Motif Blast Search and Protein Mass Prediction 
 The aminopeptidase predicted amino acid sequences of E. hellem human, 
E. hellem bird and E. cuniculi were subjected to protein motif searches using Prosite, 
ExPASY, Swiss Institute of Bioinformatics (SIB), and the predicted mass was 
calculated using Peptide Mass, ExPASY, SIB (http://us.expasy.org/tools/peptide-
mass.html and http://us.expasy.org/). 
 In addition the GenBank sequences for E. cuniculi zinc metalloprotease, 
glutamyl and leucine aminopeptidases (GenBank accession nos. CAA06646, 
NP_597136, NP_586294) were also subjected to protein motif searches using Prosite 
and ExPASY (SIB), and the predicted mass was calculated using Peptide Mass, 
ExPASY (SIB). 
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Results 
Homology PCR and Aminopeptidase Gene Acquisition 
 Homology PCR to acquire an aminopeptidase gene fragment from E. cuniculi 
generated a 600 bp amplicon that was successfully ligated and cloned.  The resulting 
sequence was subjected to a BLAST search and shared 100 % identity with E. cuniculi 
aminopeptidase (GenBank accession no. CAA06646).  E. hellem homology PCR also 
generated a 600 bp amplicon that was successfully cloned and sequenced.  A BLAST 
search of the obtained sequence showed a 71 % identity shared with E. cuniculi 
aminopeptidase (GenBank accession no. CAA06646) and glutamyl aminopeptidase 
(GenBank accession nos. NP586759 and CAD24886).  The sequence matched the 
E. cuniculi aminopeptidase sequences more closely than any other sequences in the 
database.  E. hellem specific primers, Primer 3 and Primer 4 (Table 2.1), were 
designed from the obtained 600 bp sequence and used to obtain the full length 
aminopeptidase genes from E. hellem (bird) cDNA.   
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E. hellem (bird) 3' and 5' RACE reactions generated approximately 2000 bp 
and 600 bp amplicons, respectively, that were successfully cloned and sequenced.  The 
full length aminopeptidase gene was obtained by aligning the overlapping sequences 
and included the start methionine codon, polyadenylation signal and stop codon.  The 
open reading frame was 2598 bp and 865 predicted amino acids (Fig. 2.1 and Fig. 
2.2).  From this sequence E. hellem specific 5' and 3’ primers, Primers 9 and 10 (Table 
2.1), were designed to amplify the aminopeptidase gene sequences from E. hellem 
(human) cDNA and E. hellem (bird and human) gDNA.  The open reading frame was 
2995 bp and 864 predicted amino acids and included the start methionine but lacked 
the stop codon.  The aminopeptidase gene sequence of E. cuniculi was successfully 
obtained from gDNA using a nested PCR protocol that produced 2 overlapping 
fragments yielding a gene of approximately 2600 bp with a predicted amino acid 
sequence of 863 residues (Figs. 2.1 and 2.2).  
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EH  ATGAAGTGGATTGAATTGATGATTGGATTGATGCCCATGATTGAAGGCAGAAAAATGGAA 60 
Mu5 AGTGGATTGAATTGATGATTGGATTGATGCCCATGATTGAAGGCAGAAAAATGGAA 60  ATGA
  ≡≡≡        PRIMER 9 
EH  GGAAGCAGTGGGACAGAATTTCCTCGAAGGCTGGACAGGACTGTTGTTCCTTCGCACTAC 120 
Mu5 GGAAGCAGTGGGACAGAATTTCCTCGAAGGCTGGACAGGACTGTTGTTCCTTCGCACTAC 120 
                 
EH  GACCTGCATGTGAAGGTGATGGACACGGGGTTCTGCGGAAACGTAGGGATCCGGGTGGAT 180 
Mu5 GACCTGCATGTGAAGGTGATGGACACGGGGTTCTGCGGAAACGTAGGGATCCGGGTGGAT 180 
                 
EH  ATCTCGCAGCCTGTGGATGAGATAATGATGAATGCAAAGGAGCTTGACGTGCTGAGTGCA 240 
Mu5 ATCTCGCAGCCTGTGGATGAGATAATGATGAATGCAAAGGAGCTTGACGTACTGAGTGCA 240 
                          
EH  GGGATTGAGATTGATGGAAGGAGGATTGATGGAGAGGTGGTCATGGGAGACGACGAGAAG 300 
Mu5 GGGATTGAGATTGATGGAAGGAGGATTGATGGAGAGGTGGTCATGGGAGACGACGAGAAG 300 
                 
EH  GAGTACGAGGTTGTAAGGATCAGGTTTCCCTCGACGAYACCCAAGGGAGAAGGATACATT 360 
Mu5 GAGTACGAGGTTGTAAGGATCAGGTTTCCCTCGACGATACCCAAGGGAGAAGGATACATT 360 
                      PRIMER 11 
EH  GTGGGAGAGTTCTGCGGAGACTACAACTCTGGTCTGGTTGGGTTTTACAAGAGCGGGGGA 420 
Mu5 GTGGGAGAGTTCTGCGGAGACTACAACTCTGGTCTGGTTGGGTTTTACAAGAGCGGGGGA 420 
                 
EH  GAGTCGAAGGTCTACAGCACACACTTTGAGCCGACGGATGCAAGAAGGGTGTTTCCATGC 480 
Mu5 GAGTCGAAGGTCTACAGCACACACTTTGAGCCGACGGATGCAAGAAGGGTGTTTCCATGC 480 
                
EH  TTTGACCAGCCCGATATGAAGGCAACGTTTAGCATTTCGATTGATGCGCCGTCAAACCTT 540 
Mu5 TTTGACCAGCCCGATATGAAGGCAACGTTTAGCATTTCGATTGATGCGCCGTCAAACCTT 540 
                 
EH  GTTGTTCTGTCGAACAGCCCCTCTGTGCCTTCGCTGCGGAAGGAGTATGGAGACAGGGCG 600 
Mu5 GTTGTTCTGTCGAACAGCCCCTCTGTGCCTTCGCTGCGGAAGGAGTATGGAGACAGGGCG 600 
                                          PRIMERS 3 & 4  
EH  ATTGAGTACTTCACGAAGACAAGCAAGATGTCTACATATCTTGTTGCATTTGTTGCTGGC 660 
Mu5 ATTGAGTACTTCACGAAGACAAGCAAGATGTCTACATATCTTGTTGCATTTGTTGCTGGC 660 
 
                 
EH  GAGCTTGAGTACATTGAGGACTGGAGCAAGTCTGGAGTGAGGCTAAGGGTGTATGGACAG 720 
Mu5 GAGCTTGAGTACATTGAGGACTGGAGCAAGTCTGGAGTGAGGCTAAGGGTGTATGGACAG 720 
                           PRIMER 12 
EH  GGGAAGGAAGAGGCGTCGTGGGGAAGGTATGGGCTTGAGGTTGCAAAGAGATGCATCGAC 780 
Mu5 GGGAAGGAAGAGGCGTCGTGGGGAAGGTATGGGCTTGAGGTTGCAAAGAGATGCATCGAC 780 
 
Fig. 2.1.  Nucleotide aminopeptidase sequence alignment of E. hellem human (EH) 
and bird (Mu5) isolates obtained from cDNA. The nucleotides underlined represent 
primer locations, bolded nucleotides differ between bird and human isolates with no 
change in the predicted amino acid sequences, nucleotides bolded and underlined 
differ between sequences and differ in the predicted amino acid sequence.  The 
methionine start codon is triple underlined and the polyadenylation signal is double 
underlined.  
 
 37
 
EH  TACTTTGAGGAGTACTTTGGGATTGAGTATGAGTTTCCTGAGAAGGGGATGGCAAAGATA 840 
Mu5 TACTTTGAGGAGTACTTTGGGATTGAGTATGAGTTTCCTGAGAAGGGGATGGCAAAGATA 840 
      
EH  GACATGATTGGGATTCCGAGCTTTGGCAGTGGAGCGATGGAGAACTGGGGGCTCATTACG 900 
Mu5 GACATGATTGGGATTCCGAGCTTTGGCAGTGGAGCGATGGAGAACTGGGGGCTCATTACG 900 
            PRIMER 5 
EH  TTCCGAAAGGAGAGTCTTCTGTACTCTGATGGAAAGGACAGTGTTGAGCAAAAGAAGAAT 960 
Mu5 TTCCGAAAGGAGAGTCTTCTGTACTCTGATGGAAAGGACAGTGTTGAGCAAAAGAAGAAT 960 
      
EH  GTAGCTGAAACTGTGTGCCACGAGCTGGGGCACATGTGGTTTGGAAACCTTGTGACGATG 1020 
Mu5 GTAGCTGAAACTGTGTGCCACGAGCTGGGGCACATGTGGTTTGGAAACCTTGTGACGATG 1020 
      
EH  GAGTGGTGGGACGACCTRTGGCTGAACGAGGGATTTGCAACATGGATATCGTTCAAGGGG 1080 
Mu5 GAGTGGTGGGACGACCTGTGGCTGAACGAGGGATTTGCAACATGGATATCGTTCAAGGGG 1080 
      
EH  ATGTCTGAGATAGGAAAGGAGTATGTTGACTGGGATGTCGAGGGAGAGTTTGTGCTGTGG 1140 
Mu5 ATGTCTGAGATAGGGAAGGAGTATGTTGACTGGGATGTCGAGGGAGAGTTTGTGCTGTGG 1140 
                    
EH  AATGTGATACGGGGGATGCTTGAGGATGGGCTTGGAAAGAGCCACAAGATCCGGATGGAG 1200 
Mu5 AATGTGATACGGGGGATGCTTGAGGATGGGCTTGGAAAGAGCCACAAGATCCGGATGGAG 1200 
      
EH  GTTTCCGATCCTGGAGAGATTGGAGAGATCTTTGATGCGATCAGCTACAGCAAGGGAGCA 1260 
Mu5 GTTTCCGATCCTGGAGAGATTGGAGAGATCTTTGATGCGATCAGCTACAGCAAAGGAGCA 1260 
              
EH  AGCATCGTCAGGATGGTTGAGAAGTATGTTGGGGAGTCTGTATTTATGTCTGGGATCCGG 1320 
Mu5 AGCATCATCAGGATGGTTGAGAAGTATGTTGGGGAGTCTGTATTTATGTCTGGGATCCGG 1320 
     PRIMER 6 
EH  CGATACATCAAGGAGCACATGTATGGGAACGGGAATGGAATGAGCCTGTGGAAGGCGATT 1380 
Mu5 CGATACATCAAGGAGCACATGTATGGGAACGGGAATGGAATGAGCCTGTGGAAGGCGATT 1380 
      
EH  GGGGAGTCCTATGGAAAGGACATTTCGTCGATGGTTGAGGGATGGATTTCGCAGGCAGGA 1440 
Mu5 GGGGAGTCCTATGGAAAGGACATTTCGTCGATGGTTGAGGGATGGATTTCGCAGGCAGGA 1440 
 
EH  TACCCTGTGATAAGTGTCAGCGAGAGTGGGGAGAACCTCGTTCTATCGCAGAGGAGATAC 1500 
Mu5 TACCCTGTGATAAGTGTCAGCGAGAGTGGGGAGAACCTCGTTCTGTCGCAGAGGAGATAC 1500 
      
EH  TCGATGCTTGGAAAAAGCGACGACAGCATGTGGATTGTACCTGTTGTGATAACATGGGGG 1560 
Mu5 TCGATGCTTGGAAAAAGCGACGACAGCATGTGGATTGTGCCTGTTGTGATAACATGGGGG 1560 
            PRIMER 8  
EH  TCTGGAGAGAACGAAAGCATTGAGGTTGGAGAGAGAGAGGTTGTGATTCCACGGAGGAGC 1620 
Mu5 TCTGGAGAGAACGAAAGCATTGAGGTTGGAGAGAGAGAGGTTGTGATTCCACGGAGAAGC 1620 
      
EH  GATGTGTACAAGGTGAACAGCTCGTATGCAGGGTTCTACCGGGTGCTGTACGAGGCCGAT 1680 
Mu5 GATGTGTACAAGGTGAACAGCTCGTATGCAGGGTTCTACCGGGTGCTGTACGAGGCCGAT 1680 
     
EH  GCACTGAGAAGGCTTGAGGAGAGGCTTGAGGAGATGGGCGACATGGACCGAGTGAACATG 1740 
Mu5 GCACTGAGAAGGCTTGAGGAGAGGCTTGAGGAGATGGGCGACATGGACCGAGTGAACATG 1740 
      
Fig. 2.1 continued. 
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EH  GTCGAGGATGTGTTTGGGCTTGGATTTGGACTGTATGGAGGGATTGGAGAGAGGCTCCGG 1800 
Mu5 GTCGAGGATGTGTTTGGGCTTGGATTTGGACTGTATGGAGGGATTGGAGAGAGGCTCCGG 1800 
      
EH  AAGATAGGGGAGTACTACTCTGACGGATACTGTGTTGCCCGAAGCACGGTTGAGAAGCTG 1860 
Mu5 AAGATAGGGGAGTACTACTCTGACGGATACTGTGTTGCCCGAAGCACGGTTGAGAAGCTG 1860 
              PRIMER 13 
EH  ATGCGGATCCGGAGTGTGTTCTACGACGATGCCGAGATTGTGTCTGCGGTTGACAAGCGA 1920 
Mu5 ATGCGGATCCGGAGTGTGTTCTACGACGATGCCGAGATTGTGTCTGCGGTTGACAAGCGA 1920 
 
EH  GTTCTGGGGCTGATTGAGGAGAGGATTGAGTCTATTGACACCTCTGTGTGTGAGACGTCT 1980 
Mu5 GTTCTGAGGCTGATTGAGGAGAGGATTGAGTCTATTGACACCTCTGTGTGTGAGACGTCT 1980 
      
EH  GTGGAAAGGATCAGCATGAACAAGTACCTGCTGTCTGTTGGCATTGAGGTTGGAAGTGCC 2040 
Mu5 GTGGAAAGGATCAGCATGAACAAGTACCTGCTGTCTGTTGGCATTGAGGTTGGAAGTGCC 2040 
      
EH  TCTGCGATGAGGAAGGTGTCTGAGCTGTGGAGGCGGCACGTCGAGGAGGGAGCGGAGCTT 2100 
Mu5 TCTGCGATGAGGAAGGTGTCTGAGCTGTGGAGGCGGCACGTCGAGGAGGGAGCGGAGCTT 2100 
      
EH  GGAGAACTTCGGTGGATTGTGTACAAGGGAGTTGTTGACGACAACCTTGAGCACCTGATT 2160 
Mu5 GGAGAACTTCGGTGGATTGTGTACAAGGGAGTTGTTGACGACAACCTTGAGCACCTGATT 2160 
              PRIMER 14 
EH  GGGGAGTACAAGAGTGGAAGGAGGCCTGGAGCCCGATGGGAGGTGATAAATGGGTTCAGC 2220 
Mu5 GGGGAGTACAAGAGTGGAAGGAGGCCTGGAACCCGATGGGAAGTGATAAGTGGGTTCAGC 2220 
      
EH  GGGATAAAGAGGAAGGAGAGCTTTGCAGAGGTTGTGAAGAGGCTGTGCGAGTTCAGTGTT 2280 
Mu5 GGGATAAAGAGGAAGGAGAGCTTTGCGGAGGTTGTGAAGAGGCTGTGCGAGTTCAGTGTT 2280 
 
EH  GAGGACATTGGTGTGGTGATAGCAATAATCTGCAGAAGCGGGAACTTCCGTGACGAGATG 2340 
Mu5 GAGGACATTGGTGTGGTGATAGCAATAATCTGCAGAAGCGGGAACTTCCGTGACGAGATG 2340 
      
EH  GTTGAGTATGTTGTGTCGCACCGGGAGGAGCTTTATTCGATGGTGCAGAAGAATGTGATG 2400 
Mu5 GTTGAGTATGTTGTGTCGCACCGGGAGGAGCTTTATTCGATGGTGCAGAAGAATGTGATG 2400 
                          PRIMER 7 
EH  CTATACAACACCATTGTGATGTCTCTCCGGCATGTGAGCAGTGACCCAATGGTGGAGAAA 2460 
Mu5 CTATACAACACCATTGTGATGTCTCTCCGGCATGTGAGCAGTGACCCAATGGTGGAGAAA 2460 
      
EH  GTGTCTGAGTTCCTTTCTGGGATCAAGCACTCTGGAAGCAGTCTGAGCATTGAGAAGGTG 2520 
Mu5 GTGTCCGAGTTCCTTTCTGGGATCAAGCACTCTGGAAGCAGTCTGAGCATTGAGAAGGTG 2520 
      
EH  CGAGACGAGATTGAGTGGAGAAGAAGGATGAGAGGAGTAAGAGACGAGATCCTTGCAGGA 2580 
Mu5 CGAGACGAGATTGAGTGGAGAAGAAGGATGAGAGGAGTAAGAGACGAGATCCTTGCAGGA 2580 
      
EH  CTCTGCTCCTCTGA---------------------------------------------- 2595 
Mu5 CTCTGCTCCTCTGAGTGAATAAACAGGGTTCTCTGTAAAAAAAAAAAAAAAAAAAAAAAA 2640 
       PRIMER 10                                                 ==  === 
 
Fig. 2.1 continued. 
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EH  WIELMIGLMPMIEGRKMEGSSGTEFPRRLDRTVVPSHYDLHVKVMDTGFCGNVGIRVD 60 K
Mu5 WIELMIGLMPMIEGRKMEGSSGTEFPRRLDRTVVPSHYDLHVKVMDTGFCGNVGIRVD 60 K
Ec  WIKVMAGLLPMIGSKGADEKDSSQQ-RRLSRVVVPEHYDLHVKILDAGFCGSVGIRVM 59 MR≡
    *:**::* **:*** .:  : ...::  ***.*.***.*******::*:****.*****  
EH  ISQPVDEIMMNAKELDVLSAGIEIDGRRIDGEVVMGDDEKEYEVVRIRFPS GYI 120 E 
Mu5 ISQPVDEIMMNAKELDVLSAGIEIDGRRIDGEVVMGDDEKEYEVVRIRFPSTIPKGEGYI 120 
Ec  ISQDVSEIVLNAKELEIRDAGIVVEGARIPGRVVVGEAEKELEVVRIVFPSSLRAGPGYL 119 
    *** *.**::*****:: .*** ::* ** *.**:*: *** ***** ***:   * **: 
EH  VGEFCGDYNSGLVGFYKSGGESKVYSTHFEPTDARRVFPCFDQPDMKATFSISIDAPSNL 180 
Mu5 VGEFCGDYNSGLVGFYKSGGESKVYSTHFEPTDARRVFPCFDQPDMKATFSISIDAPSNL 180 
Ec  TMEFCGDYSNGLVGLYKSGGPKEVYSTHFEPTDARRAFPCFDQPDMKATFKISIDAGSKF 179 
    . ******..****:***** .:**** ***.*************.***** *:: 
EH  VVLSNSPSVPSLRKEYGDRAIEYFTKT
Mu5 VVLSNSPSVPSLRKEYGDRAIEYFTKT
Ec  TVLANTQAIPSLREEYGDRKIEYFEET
    .**:*: ::****:***** **** :*
EH  GKEEASWGRYGLEVAKRCIDYFEEYFG
Mu5 GKEEASWGRYGLEVAKRCIDYFEEYFG
Ec  S-SEVEWGRYGLEVGKRCLEYFSEYFG
    . .*..********.***::**.****
EH  FRKESLLYSDGKDSVEQKKNVAETVCHH
Mu5 FRKESLLYSDGKDSVEQKKNVAETVCH
Ec  FRRESLLYVPGKSNVEDMKNVAGTVCH
    **:*****  **..**: **** ****
Fig.2.2.  E. hellem human isolate (EH
(Ec) aminopeptidase predicted amin
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alignment program to maximize th
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 ******Primer 1SKMSTYLVAFVAGELEYIEDWSKSGVRLRVYGQ 240 
SKMSTYLVAFVAGELEYIEDWSKSGVRLRVYGQ 240 
CKMSTYLVAFVVGELSYIEDWSKDGVRLRVYGD 239 
.**********.***.*******.********: 
IEYEFPEKGMAKIDMIGIPSF LIT 300 GSGAMENWG  GAMEN 
IEYEFPEKGMAKIDMIGIPSFGSGAMENWGLIT 300 
VGYEFPRAGSAKIDMVGIPNFSSGAMENWGLIT 298 
: ****. * *****:***.*.*********** 
WFGNLVTMEWWDDLWLNEGFATWISFKG 360 ELGHMEXXH 
ELGHMWFGNLVTMEWWDDLWLNEGFATWISFKG 360 
ELGHMWFGNLVTMSW NEGFATWVSFKG 358 
*************.* *******:**** 
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erisks (*) and sim
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EH  MSEIGKEYVDWDVEGEFVLWNVIRGMLEDGLGKSHKIRMEVSDPGEIGEIFDAISYSKGA 420 
Mu5 MSEIGKEYVDWDVEGEFVLWNVIRGMLEDGLGKSHKIRMEVSDPGEIGEIFDAISYSKGA 420 
Ec  MENIG-SVVSWDVWGEFVLWNVVRGMVDDGLGKSHQIRMNVTDPGEIGEIFDSISYCKGA 417 
    *.:** . *.*** ********:***::*******:***:*:**********:***.*** 
EH  SIVRMVEKYVGESVFMSGIRRYIKEHMYGNGNGMSLWKAIGESYGKDISSMVEGWISQAG 480 
Mu5 SIIRMVEKYVGESVFMSGIRRYIKEHMYGNGNGMSLWKAIGESYGKDISSMVEGWISQAG 480 
Ec  SVIRMIERYVGESVFMLGIRRYIKEHMYGNGNAMSLWKAIGEEYGEDISEMVEGWISQAG 477 
    *::**:*:******** ***************.*********.**:***.********** 
EH  YPVISVSESGENLVLSQRRYSMLGKSDDSMWIVPVVITWGSGENESIEVGEREVVIPRRS 540 
Mu5 YPVISVSESGENLVLSQRRYSMLGKSDDSMWIVPVVITWGSGENESIEVGEREVVIPRRS 540 
Ec  YPVVSVQDCGSSLVLSQSRYSMLGKSDDSLWTIPVVVSWEGKGQERIELRGRETTVRKRS 537 
    ***:**.:.*..***** ***********:* :***::* .  :* **:  **..: :** 
EH  DVYKVNSSYAGFYRVLYEADALRRLEERLEEMGDMDRVNMVEDVFGLGFGLYGGIGERLR 600 
Mu5 DVYKVNSSYAGFYRVLYEADALRRLEERLEEMGDMDRVNMVEDVFGLGFGLYGGIGERLR 600 
Ec  SVYKVNAEYGGFYRVLYDSAGLSGLESRIDSLSVVDRVNVIEDVFGLGFGLYGGLEHGLR 597 
    .*****:.*.*******:: .*  **.*::.:. :****::*************: . ** 
EH  KIGEYYSDGYCVARSTVEKLMRIRSVFYDDAEIVSAVDKRVLGLIEERIESIDTSVCETS 660 
Mu5 KIGEYYSDGYCVARSTVEKLMRIRSVFYDDAEIVSAVDKRVLRLIEERIESIDTSVCETS 660 
Ec  RISEYYSDSYHVARSGIEKLLRLRSVFYDDAEIVSLIDKKVRKMILPCVGRIDVFDIGTS 657 
    :*.*****.* **** :***:*:************ :**:*  :*   :  **.    ** 
EH  VERISMNKYLLSVGIEVGSASAMRKVSELWRRHVEEGAELGELRWIVYKGVVDDNLEHLI 720 
Mu5 VERISMNKYLLSVGIEVGSASAMRKVSELWRRHVEEGAELGELRWIVYKGVVDDNLEHLI 720 
Ec  VESVSMNKYVLSVGVEVGIREAVEKVQELWRRHVEAGEELGELRWIVYKAVVDENLGYMM 717 
    ** :*****:****:***  .*:.**.******** * ***********.***:** ::: 
EH  GEYKSGRRPGARWEVINGFSGIKRKESFAEVVKRLCEFSVEDIGVVIAIICRSGNFRDEM 780 
Mu5 GEYKSGRRPGTRWEVISGFSGIKRKESFAEVVKRLCEFSVEDIGVVIAIICRSGNFRDEM 780 
Ec  DKHKYGDTPGMRREVMNGFSGIKREENFLDVVGNLSQFSVEDIGVVIGSISRGGAFRDAM 777 
    .::* *  ** * **:.*******:*.* :** .*.:**********. *.*.* *** * 
EH  VEYVVSHREELYSMVQKNVMLYNTIVMSLRHVSSDPMVEKVSEFLSGIKHSGSSLSIEKV 840 
Mu5 VEYVVSHREELYSMVQKNVMLYNTIVMSLRHVSSDPMVEKVSEFLSGIKHSGSSLSIEKV 840 
Ec  VEYVVSHGEELYLMVHKNAMLYNMIIMSLRHVSGDLIVEKVERFLSGIKHSGSNLSIEKV 837 
    ******* **** **:**.**** *:*******.* :****..**********.****** 
 
Fig.  2.2 continued. 
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EH  RDEIEWRRRMRGVRDEILAGLCSSE----------------------------------- 865 
Mu5 RDEIEWRRRMRGVRDEILAGLCSSEINRVLCKKKKKKKKKKVLCVVTTACPIVSRIRRAN 900 
Ec  RNEIQWRRRMRGIREEVLRGLLPEAEK--------------------------------- 864 
    *:**:*******:*:*:* ** ..                                     
Fig. 2.2 continued. 
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Aminopeptidase Gene Sequence Alignments 
E. hellem (bird) cDNA and gDNA  
Three differences were observed in the aligned aminopeptidase gene 
nucleotide sequences obtained from the E. hellem bird isolate cDNA and gDNA.  At 
position 1485, an A in the cDNA sequence was replaced with G in the gDNA 
sequence, resulting in no change in the predicted amino acid sequences.  At position 
1927, 2 different cDNA clones had an A or a G resulting in codons for arginine or 
glycine, respectively.  In the gDNA sequence, a G was in position 1927, predicting 
glycine.  At position 2248, a G was found in the cDNA sequence and an A in the 
gDNA sequence, resulting in no change in the predicted amino acid sequence.  
E. hellem (human) cDNA and gDNA 
Six differences were observed in the aligned aminopeptidase gene nucleotide 
sequences obtained from the E. hellem human isolate cDNA and gDNA.  At position 
338, 2 different cDNA clones had a C or a T resulting in codons for threonine or 
isoleucine, respectively.  In the gDNA sequence, a T was in position 338 predicting 
isoleucine.  At position 375, a C in the cDNA sequence was replaced with T in the 
gDNA sequence, resulting in no change in the predicted amino acid sequences.  At 
position 1038, 2 different cDNA clones had an A or a G the gDNA sequence, resulting 
in no change in the predicted amino acid sequences.   At position 1267, a G in the 
cDNA sequence predicts a valine and was replaced with an A in the gDNA sequence, 
which predicts isoleucine.   At position 1539, an A in the cDNA sequence was 
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replaced with G in the gDNA sequence, resulting in no change in the predicted amino 
acid sequences.  At position 1617, a G in the cDNA sequence was replaced with A in 
the gDNA sequence, resulting in no change in the predicted amino acid sequences.   
E. hellem (bird) and E. hellem (human) cDNA nucleotide sequence comparison 
The cDNA aminopeptidase nucleotide sequences obtained from E. hellem bird 
and human isolates were aligned and compared.  The sequences were >99 % identical.  
Differences were observed at 14 different positions (231, 338, 1254, 1267, 1617, 
1927, 1095, 1485, 1539, 2191, 2202, 2210, 2247 and 2466) resulting in differences in 
the predicted amino acids at 4 of these positions (338, 1267, 2191, and 2210) (Table 
2.2 and 2.3). 
At positions 231, 1254, 1617, 1927 and 2202, a G in the human cDNA 
sequence was replaced with an A in the bird isolate cDNA sequence.  At positions 
1095, 1485, 1539, and 2247, an A in the human cDNA sequence was replaced with a 
G in the bird isolate cDNA sequence.  At position 2466, a T in the human cDNA 
sequence was replaced with a C in the bird isolate cDNA sequence.  These 
substitutions resulted in no changes in the predicted amino acid sequences (Table 2.2 
and Fig. 2.1).     
At position 338, 2 different human isolate cDNA clones had a C or a T 
resulting in codons for threonine or isoleucine, respectively.  At position 338, the bird 
isolate cDNA clone had a T and predicted threonine.  At position 1267, a G in the 
human cDNA sequence was replaced with an A in the bird isolate cDNA sequence, 
predicting valine and isoleucine, respectively.  At position 2191, a G in the human 
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cDNA sequence was replaced with an A in the bird isolate cDNA sequence, predicting 
alanine and threonine, respectively.  At position 2210, an A in the human cDNA 
sequence was replaced with a G in the bird isolate cDNA sequence, predicting 
arginine and serine, respectively (Table 2.3 and Fig. 2.1 and 2.2).  
To summarize, there were 4 differences among the E. hellem aminopeptidase 
nucleotide sequences that resulted in changes in the predicted amino acid sequences.  
Due to a C substituted for a T at position 338, threonine was encoded for by 1 human 
isolate cDNA clone, but the sequences from a second human isolate cDNA clone and 
gDNA, and the bird isolate cDNA and gDNA all coded for isoleucine with a T at this 
position.  Next, at position 1267, the E. hellem human isolate cDNA sequence contains 
a G predicting valine and the gDNA sequence contains an A and predicts isoleucine, 
while the cDNA and gDNA sequences of the bird isolate contain an A.  At position 
2191, the E. hellem human isolate cDNA and gDNA sequences have a G at this 
position and predict an alanine.  The bird cDNA and gDNA sequences have an A and 
predict a threonine.   Lastly, at position 2210, the E. hellem human isolate cDNA and 
gDNA sequences contain an A and predict asparagine while the bird cDNA and 
gDNA sequences have a G and predict a serine (Table 2.3, Fig. 2.1 and 2.2).  
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Table 2.2.  Silent nucleotide differences in the E. hellem aminopeptidase gene 
sequences.  
 
Isolate Sequence Position Nucelotide Isolate Sequence Position Nucelotide
          
human cDNA 231 G human cDNA 1617 G 
bird  cDNA 231 A bird  cDNA 1617 A 
human cDNA 1095 A human cDNA 1927 G 
bird  cDNA 1095 G bird  cDNA 1927 A 
human cDNA 1254 G human cDNA 2202 G 
bird  cDNA 1254 A bird  cDNA 2202 A 
human cDNA 1485 A human cDNA 2247 A 
bird  cDNA 1485 G bird  cDNA 2247 G 
human cDNA 1539 A human cDNA 2466 T 
bird  cDNA 1539 G bird  cDNA 2466 C 
 
 
 
Table 2.3.  Nucleotide differences in the E. hellem aminopeptidase gene sequences 
resulting in a change in the predicted amino acid.  
  
Isolate Sequence Position Nucelotide Position Predicted  
          amino acid 
human cDNA 338 T/C  113 Isoleucine/  
     Threonine 
bird cDNA 338 A  113 Isoleucine 
human cDNA 1267 G  422 Valine 
bird cDNA 1267 A  422 Isoleucine 
human cDNA 2191 G  731 Alanine 
bird cDNA 2191 A  731 Threonine 
human cDNA 2210 A  737 Aspargine 
bird cDNA 2210 G  737 Serine 
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E. cuniculi (rabbit) and E. cuniculi GenBank CAA06646 
The E. cuniculi aminopeptidase sequence obtained in this study was 100 % 
identical to the E. cuniculi zinc metalloprotease sequence in the GenBank database 
(GenBank accession no. CAA06646).  The sequence was also aligned and compared 
with an E. cuniculi glutamyl aminopeptidase (GenBank accession no. NP_597136) 
and only 3 substitutions in the predicted amino acid sequences were observed, 
resulting in an identity value of  >99 %. 
E. hellem human and bird and E. cuniculi predicted amino acid sequences 
The aligned predicted amino acid sequences of E. hellem human and bird 
aminopeptidases shared >99% identity.   The E. hellem human and bird predicted 
aminopeptidase sequences shared >69% identity with the E. cuniculi aminopeptidase 
predicted amino acid sequence. 
 
Protein Motif Blast Search and Protein Mass Prediction 
 The predicted mass of the aminopeptidase sequences of each isolate was 
approximately 97 kDa.  Similarity searches based on conserved protein motifs 
identified HEXXH zinc binding region and GAMEN motifs.  These motifs classify the 
enzymes as zinc metalloproteases of the M1 family of aminopeptidases.   
 Protein mass predictions of the E. cuniculi zinc metalloprotease, glutamyl 
and leucine amipeptidase sequences (GenBank accession nos. CAA06646, 
NP_597136, NP_586627) were approximately 97, 97, and 70 kDa, respectively.   
Similarity searches based on conserved protein motifs identified HEXXH zinc binding 
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region and GAMEN motifs in the zinc metalloprotease and glutamyl aminopeptidase 
sequences (GenBank accession nos. CAA06646 and NP_597136), also classifying 
these aminopeptidase as a zinc metalloprotease of the M1 family of aminopeptidases.  
Similarity searches of the leucine aminopeptidase sequence (GenBank accession no. 
NP_586627) classify this enzyme under the M17 family of aminopeptidases.   
 
Discussion 
The E. hellem and E. cuniculi aminopeptidases reported here show sequence 
homology with other aminopeptidases classified under the M1 family in the MA clan 
of aminopeptidases.  The sequences contain the conserved HEXXH + E zinc binding 
and GAMEN motifs (Fig. 2.2), and thereby indicate that the sequences code for 
metalloproteases with at least one zinc atom required for catalytic activity (Rawlings 
& Barret, 1995).  These conserved motifs showed sequence homology with 
aminopeptidases of other organisms such as Caenorhabditis elegans, Haemonchus 
contortus, and Aspergillus niger (GenBank accession nos. NP_5501220.1; 
CAB57357.1; CAC38353.1).      
Members of the M1 family of aminopeptidases include membrane bound and 
cytosolic aminopeptidases, and many members are heavily glycosylated (Rawlings & 
Barrett, 1995).  Members of the M1 family include E. coli aminopeptidase N; 
alanine/arginine aminopeptidase from Saccharomyces cerevisiae; leucine 
aminopeptidase (lap) from Lactococcus lactis; lysine aminopeptidase of A. niger; 
arginine aminopeptidase of C. parvum and zinc metallopeptidase of P. falciparum 
(Taylor, 1993; Okhuysen et al. 1994; Rawlings & Barrett, 1995; Florent et al. 1998; 
 
 48
Basten, Visser & Schaap, 2001; Allary, Schrevel & Florent, 2002).  Interestingly, 
although aminopeptidases may show preferential cleavage of certain substrates, many 
members of the M1 family demonstrate the ability to cleave a variety of substrates.  
Examples are the aminopeptidase of P. falciparum, which efficiently hydrolyzes 
lysine, alanine, arginine, and leucine (Allary et al. 2002); the arginine aminopeptidase 
of C. parvum which can hydrolyze alanine, phenylalanine, glycine, and leucine as well 
(Okhuysen et al. 1994); and the lysine aminopeptidase of A. niger which also cleaves 
arginine, methionine, alanine, leucine, and phenylalanine (Basten et al. 2001).   
The obtained open reading frames of the E. hellem bird isolate, E. hellem 
human and E. cuniculi produced predicted amino acid sequences of 865, 864, and 863 
residues, respectively.  The E. hellem human and E. cuniculi aminopeptidase genes 
were acquired by PCR, thus the ends are incomplete compared to the sequence 
produced by RACE for E. hellem bird.  Also E. cuniculi has a three base deletion 
within the gene resulting in a shorter amino acid sequence.  No introns were found in 
the genomic DNA sequences of either the E. cuniculi or E. hellem aminopeptidases in 
this study.  This is consistent with previous data, which has found only a single intron 
in the entire genome from E. cuniculi, located at the beginning of the large subunit 
ribosomal protein of E. cuniculi (Biderre et al. 1998).   
The E. hellem isolates shared >99 % identity of both nucleotide and predicted 
amino acid sequences.  A few differences were observed at the nucleotide level 
between cDNA and gDNA sequences of the same E. hellem isolate and between the 
cDNA sequences of the two E. hellem isolates.  Most of these differences did not 
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change the predicted amino acid sequence and were therefore likely due to codon 
usage.  Four of these differences resulted in a change in predicted amino acid 
sequences, but they did not occur at regions critical to enzyme activity.  In addition, 
the changes that were observed involved neutral substitutions, and are therefore 
probably of no consequence.  A high fidelity polymerase with proofreading activity 
was used for all PCR reactions therefore error due to PCR amplification is unlikely. 
 The E. hellem sequences shared nearly 70 % identity with that of E. cuniculi at 
both the nucleotide and predicted amino acid sequence levels.  The predicted amino 
acid sequence of E. cuniculi was identical to the E. cuniculi zinc metalloprotease 
(GenBank accession no. CAA06646), and was >99 % identical to that of E. cuniculi 
glutamyl aminopeptidase sequence (GenBank accession no. NP_597136).   
The E. hellem and E. cuniculi sequences correspond in length with those of 
E. cuniculi zinc metalloprotease (GenBank accession no. CAA06646) and E. cuniculi 
glutamyl aminopeptidase (GenBank accession no. NP_597136), which are 864 amino 
acids in length.  These sequences are much longer than those of E. cuniculi leucine 
and methionine (GenBank accession nos. NP_586294 and NP_586190, respectively) 
aminopeptidases, which are 486 and 358 amino acids in length, respectively.  Thus, 
the aminopeptidase genes sequenced in this study are most likely homologous to the 
E. cuniculi glutamyl aminopeptidase described in GenBank (accession no. 
NP_597136).     
The E. hellem and E. cuniculi aminopeptidase gene sequences obtained in this 
study all have predicted molecular masses of approximately 97 kDa.  The E. cuniculi 
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glutamyl aminopeptidase sequence (Genbank no. NP_597136) also has an estimated 
predicted mass of 97 kDa and the gene sequence is 99% identical to that obtained for 
E. cuniculi in this study.  The E. cuniculi aminopeptidase sequence in this study is 
identical to the GenBank sequence CAA06646, which is also 99% identical to the 
E. cuniculi glutamyl aminopeptidase (GenBank Accession No. NP_597136) and also 
has a predicted molecular mass of 97 kDa.  Although these 2 aminopeptidase genes 
(CAA06646 and NP_597136) are located on 2 different chromosomes, 1 and 8 
respectively, the high sequence identity suggests that they are homologous with 
similar functions.  It is therefore it is probable that the differences observed between 
these 2 sequences may be attributed to the fact that they represent dual copies located 
on different chromosomes. 
Based on motif and predicted mass similarities among the E. hellem 
aminopeptidase obtained in this study and the E. cuniculi aminopeptidases (GenBank 
CAA06646 and NP_597136), it is likely that these sequences code for homologous 
enzymes.  Therefore, it is likely that the E. hellem aminopeptidases are also glutamyl 
aminopeptidases.  Clearly, additional work is needed to confirm the substrate 
specificity of the E. hellem enzymes.   
There are currently 3 types of aminopeptidases, glutamyl, leucine and 
methionine (GenBank accession nos. NP_597136, NP_586294 and NP_586190, 
respectively), which have been identified in the genome of E. cuniculi (Katinka et al. 
2001).  These aminopeptidases are classified under 3 different families, M1, M17, and 
M24, respectively, based on conserved motifs identified in each sequence.  Previous 
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studies by Millership et al. (2002a, 2002b) have identified aminopeptidase activity 
from E. intestinalis, E. cuniculi and E. hellem.  The enzymatic activity was inhibited 
by bestatin and nitrobestatin in vitro and showed preferential cleavage of the substrate 
leucine.  Activity against arginine and to a lesser extent L- methionine, but not Z-
methionine, was also shown (Millership et al. 2002a; 2002b).  The estimated 
molecular masses of the aminopeptidases of E. intestinalis, E. cuniculi and E. hellem 
were 70, 74 and 72, respectively, determined by substrate gel electrophoresis 
(Millership et al. 2002a; 2002b).  It appears that these aminopeptidases from these 3 
species are homologous enzymes since they share substrate specificity and similar 
molecular masses.   
The predicted molecular masses of the E. cuniculi glutamyl, leucine, and 
methionine aminopeptidases in the GenBank database were 97, 50, and 40 kDA, 
respectively.  The aminopeptidases described by Millership et al. (2002a, 2002b) that 
preferentially cleaved leucine may or may not be homologous to the E. cuniculi 
leucine aminopeptidase (GenBank no. NP_586294).  The aminopeptidases obtained by 
Millership et al. have molecular masses ranging from 70 to 74 kDa based on substrate 
gel electrophoresis, whereas the leucine aminopeptidase has a molecular mass of 50 
kDa predicted from the amino acid sequence.  This leucine aminopeptidase possesses 
3 potential glycosylation sites.  Glycoslyation adds mass by the addition of 
carbohydrate chains, therefore, the actual molecular mass could be considerably 
greater than the predicted value if the enzyme is glycosylated,. Thus, it is possible that 
the aminopeptidase reported by Millership et al. is homologous to the reported leucine 
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aminopeptidase (GenBank no. NP_586294).  Based on the strong substrate preference 
for leucine and the limited cleavage of methionine reported by Millership et al. for the 
Encephalitozoon aminopeptidase, it is not likely that this enzyme is homologous to the 
E. cuniculi methionine aminopeptidase in the GenBank database (GenBank accession 
no. NP_586190).   
The predicted molecular mass of an identified zinc metalloprotease of 
Plasmodium falciparum is 122 kDa; the precursor protein is 120 kDa based on western 
blot analysis (Florent et al. 1998; Allary et al. 2002).  The precursor protein is further 
processed into two enzymatically active subunits, p96 and p68 (Allary et al. 2002).  If 
the 97 kDa glutamyl aminopeptidase of E. cuniculi (GenBank accession no. 
NP_597136) undergoes similar processing resulting in an active enzyme with a lower 
molecular mass, it is possible that the 70 kDa aminopeptidase obtained by Millership 
et al. could correspond to a similarly processed enzyme.  Since glutamate was not a 
substrate tested by Millership et al.(2002a, 2002b) the relationship between these 2 
enzymes is speculative at best.   
Genomes of microsporidia are characteristically very small and have very low 
copy number (Weiss et al. 1999).  The high degree of interspecies identity among the 
E. hellem and E. cuniculi aminopeptidases and the dual copies of the homologous 
genes confirmed in the E. cuniculi genome (Weiss et al. 1999) suggest that this 
enzyme may play a critical role in the life cycle of these organisms.  This enzyme 
would thus be an ideal candidate for further evaluation as a tool for drug design and 
potential therapy.    
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CHAPTER III 
IN VITRO GROWTH COMPARISONS 
Introduction 
Microsporidia are obligate intracellular spore forming parasites found 
worldwide with a wide host distribution.  Diseases caused by microsporidia have been 
documented in invertebrates, birds, mammals, and humans.  In addition, there is 
increasing evidence that some species may be zoonotic (Deplazes et al. 2000).   
Microsporidial infections with members of the genus Encephalitozoon have 
been documented in a variety of mammals and birds, as well as in human beings.  
Encephalitozoon cuniculi was first documented in rabbits (Wright & Craighead, 1922) 
and has since been described in a range of mammals, including humans and domestic 
dogs and cats (Deplazes et al. 2000).  In addition, molecular analysis of sequences of 
the intergenic transcribed spacer (ITS) region of different E. cuniculi isolates have 
classified them into 3 genotypes, 2 of which have been obtained from both human and 
animal hosts (Deplazes et al. 1996; Didier et al. 1996; Mathis et al. 1997; Snowden et 
al. 1999).  Encephalitozoon hellem was first identified from human AIDS patients in 
1991 (Didier et al. 1991a) and was later described in a number of different bird 
species (Carlisle et al. 2002).   
Molecular analyses and experimental infections of E. hellem human and bird 
isolates reveal shared characteristics between isolates.  Sequence comparisons of 
ribosomal RNA genes from avian and human isolates show nearly 100 % identity 
among isolates sequenced, suggesting conspecificity.  In addition, molecular 
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characterization of ITS regions of avian isolates classifies these isolates as genotype I, 
which is also the most frequently described genotype of human E. hellem isolates 
(Suter et al. 1998; Pulparampil et al. 1998; Snowden & Logan, 1999); Snowden et al. 
2000; Snowden et al. 2001).  Experimental infections of budgerigar chicks 
(Melopsittacus undulates) with avian and human E. hellem isolates showed no clinical 
or parasitological differences between the isolates (Snowden, personal 
communications).  A recent epidemiological survey of lovebirds identified E. hellem 
spores in 25 % of bird samples (Barton, Phalen & Snowden, 2003).       
In vivo studies, molecular analysis, and epidemiologic data support the 
probability of microsporidiosis being zoonotic.  It is also probable that birds may be 
natural hosts of E. hellem and, therefore, pet birds may pose a health risk for immune 
compromised owners.  However, further evidence is needed to prove this hypothesis.   
In this study, bird and human isolates of E. hellem and one rabbit isolate of 
E. cuniculi were evaluated under simulated avian and mammalian in vitro conditions.  
The preferred growth conditions of these parasites were evaluated based on growth 
curves derived from the numbers of spores produced by each isolate.     
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Materials & Methods 
Encephalitozoon isolates 
The bird isolate of E. hellem was isolated from droppings of a lovebird 
(Agapornis roseicollis) (Snowden et al. 2000).  The human E. hellem isolate was from 
an AIDS patient suffering from keratoconjunctivitis (Didier, 1991).  The E. cuniculi 
isolate was originally obtained from a rabbit (Shadduck, 1969).  All isolates were 
kindly provided as cryopreserved spore pellets by Dr. Karen Snowden.   
 
Spore Collection 
Spores were collected as described in Chapter II for inoculation of plated cells.      
 
Mammalian Model (Experiment 1) 
The RK-13 rabbit kidney cell line (ATCC CCL-37) was grown in 75 cm2 
flasks to confluency in Dulbecco’s modification of Eagle’s minimal essential medium 
(DMEM, Sigma, St. Louis, MO) supplemented with L-glutamine (2mM) (Gibco BRL, 
Grand Island, NY ), 5 % heat inactivated fetal bovine serum (FBS) (Sigma, St. Louis, 
MO) and antibiotic/antimycotic (Gibco BRL, Grand Island, NY) at 37 °C and a 
humidified 5 % CO2 in air atmosphere.  The cells were routinely maintained by 
discarding old media and feeding cells with 24 ml fresh media twice weekly.  Once 
cells reached confluency they were detached by trypsinization.  The medium was 
removed and the cell layers were washed with 10 ml 0.15 M phosphate-buffered saline 
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(PBS) (Sigma, St. Louis, MO).  The cells were detached from the flask by incubating 
with 5 ml trypsin (0.05% trypsin; 0.53 mM EDTA) for 5-10 min.  Cells were 
resuspended with the addition of 10 ml medium with 5 % serum to inactivate the 
trypsin.  One ml of the cell dilution was used to continue growth of the cells until 
ready for use in the experiment after approximately 8 passages.   
Cells were detached and harvested for the experiment by trypsinization as 
described above.  Percent viability was calculated using a 1:1 dilution of a 100 µl cell 
suspension sample and Trypan Blue stain.  Nonviable and viable cells were counted 
with a hemocytometer.  RK-13 cells at a concentration of 3.5 x 105 viable cells/well 
were plated in 24 well plates in 1.5 ml cell culture medium.  After 48 h the cells 
reached confluency and were inoculated with 1.5 x 106 spores/well.  Spores from the 
E. hellem human and bird isolates and E. cuniculi were collected as described in 
Chapter II, resuspended in cell culture medium and quantified using a hemocytometer 
before inoculating plates.  Three separate 24 well plates were maintained for each 
isolate.  Plates were incubated at 37 °C and a humidified 5 % CO2 in air atmosphere 
during the experiment.  Mammalian Experiment 1 was duplicated. 
 
Avian Model (Experiments 2 and 3) 
Experiment 2 
A chicken fibroblast cell line (chicken embryonic fibroblast, ATCC CRL-
12203) was grown in 75 cm2 flasks to confluency in DMEM with 2 mM L-glutamine 
containing 5 % heat inactivated chicken serum (CS) and antibiotic/antimycotic at 40 
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°C and a humidified 5 % CO2 in air atmosphere.  The cells were routinely maintained 
by removing old media and feeding cells with 24 ml fresh media twice weekly.  Once 
cells reached confluency they were detached by trypsinization.  Trypsinized cells were 
diluted in 20 ml medium and 0.5 ml of the 1:25 cell dilution was used to continue 
growth of the cells until ready for use in the experiment after approximately 4 
passages.  The cells were trypsinized and viable cells quantified as described above, 
then plated at a concentration of 1.0 x 104 viable chicken cells/well in 24 well plates.  
Plates were inoculated the following day with 5.0 x 104 spores/well with spores from 
the E. hellem human and bird isolates and E. cuniculi collected and quantified as 
described above. Three separate 24 well plates were maintained for each isolate.  
Plates were incubated at 40 °C and a humidified 5 % CO2 in air atmosphere during the 
experiment.   
Experiment 3 
 Experiment 3 was conducted as Experiment 2, except that plates were 
inoculated with 1.5 x 106 spores/ well.  Experiment 3 was duplicated.     
 
Growth Curve Determination 
The spores and cells in triplicate wells were harvested every 3 days for the 
mammalian model Experiment 1 and the avian model Experiment 2, but every 2 days 
for the avian model Experiment 3, beginning at day 2 after inoculation.  A total of 8 
time point values were obtained for each isolate for each experiment.   
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At harvests plates were first centrifuged at 800 g for 12 min to minimize the 
loss of extra-cellular spores.   Next, 1 ml of medium was removed from non-harvest 
wells and replaced with fresh medium.  All media was then removed from the harvest 
wells, and the wells were washed with PBS.  The cells were trypsinized with 1 ml 
trypsin, transferred to a 15 ml tube, and washed in 10 ml sterile tap H2O to lyse host 
cells.  Cells and spores were recovered by centrifugation for 15 min at 800 g.    The 
supernatant was discarded and the pellets were resuspended in 100 µl 1 % sodium 
dodecyl sulphate (SDS) and allowed to stand for 5 min.  The suspensions were next 
washed in H2O and centrifuged at 800 g for 15 min.  The supernatant was discarded 
and pellets were resuspended in 1 ml 1 % formalin.  The total number of spores/well 
was quantified using a hemocytometer with a minimum of 2 counts per sample.  The 
average of each count for each well was determined and the time point value then 
calculated as the average of the 2 counts of triplicate wells (6 values) for the duplicate 
experiments.  Experiment 2 was not duplicated, so each time point value was derived 
from a single set of 3 wells.  The obtained time point values were graphed to yield a 
growth curve using Graph Pad PRIZM 3.0 and the data was analyzed using Statistical 
Analysis System (SAS) software (SAS Institute 1996).     
 
Statistical Analysis 
Isolate Comparisons within Experimental Model 
Statistical methods were used to analyze differences between the growth of 
isolates under the same experimental conditions.  A mixed model with repeated 
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measures and multivariate linear regression was used for analyses.  Growth data 
(number of spores/well; 3 samples) were transformed by Log10(X) before analysis 
using SAS to test for significant differences (P value ≤ 0.05).   
Isolate Comparisons between Experimental Models  
In addition, statistical methods also were used to compare the same isolate 
under different experimental conditions at selected days post inoculation.  Data were 
analyzed by multivariate linear regression, and data (number of spores/well; 3 
samples) were Log10(X) transformed before analyses using SAS software to test for 
significant differences (P value ≤ 0.05).  Days 2, 8, and 14 post inoculation (PI) were 
selected for isolate growth comparison from the different experiments because parasite 
harvests coincided at these days.   
 
Results  
Isolate Comparisons within Experimental Model 
Mammalian Model (Experiment 1) 
 A total of 1.5 x 106 spores/well for each isolate was inoculated into 24 well 
plates with confluent RK cells.  Plates containing each isolate were maintained at 37 
°C for a duration of 24 days.  Comparative growth curves are illustrated in Fig. 3.1 
and the spore averages calculated for each y-value are located in Appendix I.  No 
statistical differences were observed between duplicate experiments.  Overall, E. 
cuniculi grew significantly better than the 2 E. hellem isolates (P≤ 0.05, Appendix 
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II).  The log phase of E. cuniculi begins at day 2 PI and continues until day 11 PI, at 
which time 3.5 x 107 spores were produced.  Days 14-24 represented a stationary 
phase with approximately the same spore count.   
The E. hellem isolates grew at similar rates.  The average numbers of spores 
were significantly different (P=0.0087) for the E. hellem isolates at day 2 PI, with the 
bird isolate growth significantly lower than that of the human isolate (P=0.0087).   
However, this represents a point in the lag phase of the microsporidial growth and did 
not appear to influence later growth since at time point 5 (day 14 PI), the bird isolate 
produced significantly more spores than the human isolate (P≤ 0.0027).  The number 
of E. hellem isolate spores steadily increased from day 5 to 20 PI, to a maximum of 
2.1 x 106 and 3.5 x 106 for the bird and human isolates, respectively.  This was 
significantly lower compared to a maximum of 3.5 x 107 for E. cuniculi on day 11.  
The number of E. hellem spores produced remained stationary between day 20 and 
day 23 PI (Fig. 3.1). 
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Fig. 3.1. In vitro growth curves of microsporidia isolates under Experiment 1 
mammalian conditions. The average number of spores/well for duplicate experiments 
at each time point is plotted for E. cuniculi (Ec ▼), E. hellem human (Eh-human ■), 
and E. hellem  bird (Eh-bird ●).  Rabbit kidney cells were inoculated with 1.5 x 106 
spores/well and maintained at 37 °C for a period of 24 days.  Lower case letters a,b 
and c represent significant differences between isolates (P ≤ 0.05).   
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Avian Model  
Experiment 2 
A total of 5.0 x 104 spores/well for each isolate was inoculated into 24 well 
plates seeded with 1.0 x 104 chicken embryonic fibroblast cells.  The plates were 
maintained at 40 °C for 24 days.  The results for Experiment 2 are graphed below (Fig. 
3.2) and the spore averages calculated for each y-value are located in Appendix I.  
Overall, the E. hellem bird isolate grew significantly better than both the E. hellem 
human isolate and the isolate of E. cuniculi (P≤ 0.05).  The numbers of spores steadily 
increased for the E. hellem bird isolate and E. cuniculi from days 2 -20 PI.  At day 20 
PI the E hellem bird isolate reached a maximum of 3.0 x 106 spores compared to 7.3 x 
105 for E. cuniculi.  Although a decrease in E. hellem bird spore number was observed 
between days 20 and 23 PI, while the number of spores remained stationary for the 
E. cuniculi isolate between these days, the E. cuniculi spore counts were significantly 
lower than the E. hellem bird counts on these days (P <0.0001, 0.0044).  The 
maximum value for E. hellem human was 5.1 x 105 on day 17, which was significantly 
lower than the corresponding value for E hellem bird (P <0.0001), but not 
significantly different from E. cuniculi (P = 0.9912).  No statistical differences were 
observed between E. cuniculi and the E. hellem human isolates at days 14-23 PI (Fig. 
3.2). 
A significant lag in growth was observed for the E. hellem human isolate 
between days 2-5 PI, which may have resulted in lower spore counts seen for 
E. hellem human for the duration of the experiment, although the curve steadily 
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increased between days 5-17 PI.  Between days 17 and 20 PI there was a slight drop in 
the E. hellem human spore count, and the counts then remained stationary between 
days 14, 17 and 23 PI.   
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Fig. 3.2. In vitro growth curves of microsporidia isolates under Experiment 2 avian 
conditions.  The average number of spores/well at each time point is plotted for 
E. cuniculi (Ec ▼), E. hellem human (Eh-human ■), and E. hellem bird (Eh-bird ●).  
Chicken cells were inoculated with 5.0 x 104 spores/well and maintained at 40°C for a 
period of 24 days.  Lower case letters a, b and c represent significant differences 
between isolates (P ≤ 0.05).   
 
 64
Experiment 3 
A total of 1.5 x 106 spores/well for each isolate was inoculated into 24 well 
plates seeded with 1.0 x 104 chicken embryonic fibroblast cells.  Plates containing 
each isolate were maintained at 40 °C, and the duration of the experiment was 16 
days.  Significant differences were not observed between the isolates for the duration 
of the experiment (P≤ 0.05, Appendix II).  Comparative growth curves of Experiment 
3 conducted in duplicate are graphed below (Fig. 3.3) and the spore averages 
calculated for each y-value are located in Appendix I.      
An increase in the number of spores was observed for all three isolates 
between days 2 and 4 PI, which subsequently decreased between days 4 and 6 PI.  
Overall the spore numbers of all 3 isolates began to increase between days 6–16 PI.  
However, a drop in parasite numbers was observed for the bird isolate of E. hellem at 
days 8 and 12 PI, but was statistically insignificant (P>0.05, Appendix II).  Although 
the numbers increased between days 6-16 PI, a typical growth curve including lag, 
logarithmic, and stationary phases was not observed.    
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Fig. 3.3.  In vitro growth curves of microsporidia isolates under Experiment 3 avian 
conditions.  The average number of spores/well at each time point is plotted for 
E. cuniculi (Ec ▼), E. hellem human (Eh-human ■), and E. hellem bird (Eh-bird ●).  
Chicken cells were inoculated with 1.5 x 106 spores/well and maintained at 40 °C for a 
period of 16 days.  Lower case letters a and b represent significant differences between 
isolates (P ≤ 0.05).   
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Isolate Growth Comparisons between Experimental Models  
The growth curves of each isolate for each experiment were graphed 
separately.  Additional statistical analyses were performed for each isolate comparing 
the average number of spores produced for each experiment at days 2, 8, and 14 PI.  
Days 2, 8, and 14 PI were chosen because harvest days coincided for each experiment 
at these days.   
At day 2 PI, the results obtained for the E. hellem human isolate in the 
mammalian model Experiment 1 and avian model Experiment 2 were significantly 
different (P= 0.1373).  At days 8 and 14 PI, significant differences were observed 
between all experiments (P<0.005, Appendix III).  The avian model Experiment 3 had 
higher numbers of spores, but a typical growth curve was not observed.   The total 
spore numbers were lower under avian model Experiment 2 compared to the 
mammalian model, however, a growth curve comparable to that under the mammalian 
model was observed.   
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At day 2 PI the growth of the E. hellem bird isolate under avian model 
Experiment 3 was significantly different than mammalian model Experiment 1 
(P<0.0001 ) and avian model Experiment 2 (P<0.0001).  Higher total numbers of 
spores were calculated under Experiment 3, but a growth curve was not observed.  
Significant differences were not observed at days 8 and 14 PI and the growth curves of 
the mammalian model and avian model Experiment 2 were comparable.   
 Significant differences were observed at days 2, 8, and 14 (P≤ 0.005) for 
E. cuniculi between mammalian and avian models.  E. cuniculi grew significantly 
better under the mammalian model. Under the avian model Experiment 2 a longer lag 
phase is observed and the logarithmic phase of the growth curve is depressed 
compared to the mammalian model.  A typical growth curve was not observed for 
Experiment 3. 
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Fig. 3.4. In vitro growth curve comparisons of E. cuniculi  and E. hellem human and 
E. hellem bird isolates under different experimental models.  a) In vitro growth curves 
of E. hellem human isolate from mammalian Experiment 1 (■) and avian model 
Experiments 2 (▲) and 3 (▼).  b)  In vitro growth curves of E. hellem bird isolate 
from mammalian Experiment 1 (■) and avian model Experiments 2 (▲) and 3 (▼).   
c) In vitro growth curves of E. cuniculi from mammalian Experiment 1 (■) and avian 
model Experiments 2 (▲) and 3 (▼).  Days 2, 8 and 16 PI were chosen for statistical 
analyses because at these days spore harvest coincided.      
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Discussion 
The purpose of the in vitro experiments was to create different culture 
conditions in order to simulate different host cell environments and to evaluate the 
microsporidian growth within these environments, thereby determining if the 
conditions in 1 model were more conducive to parasite growth.  Mammalian and avian 
models were chosen to compare isolates of E. hellem and E. cuniculi.  
E. cuniculi is a well defined mammalian microsporidia and the type species of 
the genus Encephalitozoon.  Therefore, the in vitro growth of E. cuniculi under 
mammalian conditions compared to avian conditions would reflect the natural 
preferential host conditions of the microsporidian.  A mammalian model known to 
support the in vitro growth of the control microsporidian, E. cuniculi, was chosen to 
evaluate the growth of E. hellem isolates compared to avian conditions.  E. hellem was 
first described in human infections in 1991 (Didier et al. 1991a) and was not 
documented from an avian host until 1997 (Black et al. 1997), but subsequent cases of 
avian microsporidiosis have identified E. hellem from a variety of bird species 
(Carlisle et al. 2002).  This study was designed to evaluate if E. hellem isolates 
showed preferential growth under “avian” conditions, i.e. avian cells (chicken 
embryonic fibroblasts) and serum (chicken) and 40 °C as opposed to “mammalian” 
conditions, i.e. mammalian cells (rabbit kidney) and serum (fetal bovine) and 37 °C as 
an indicator of natural host preference of these parasites.   
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The selections of in vitro parameters were based on previous studies and 
ATCC recommendations.  Rabbit kidney cells, DMEM, and FBS, which were used for 
the mammalian model, have been used in previous studies for in vitro culture of both 
E. cuniculi and E. hellem (Didier et al. 1991a; Didier et al. 1991b; Bacchi et al. 2002).  
Although a variety of cell lines have been used for the propagation of Encephalitozoon 
spp., for the purposes of these experiments an adherent, non-rapidly replicating cell 
line was necessary due to the limited growth area of the 24 well plates used in the 
experiments.  Since RK-13 cells in 24 well plates were successfully used in drug 
screening studies, this cell line was chosen for the mammalian model (Didier et al. 
1998; Millership et al. 2001; Bacchi et al. 2002)  The ATCC recommended incubation 
temperature for the RK-13 cell line at 37 °C, which is the temperature at which 
previous E. hellem and E. cuniculi isolates have been cultured (Visvesvara, 2002).  
Therefore, 37 °C was the incubation temperature selected for the mammalian model. 
The chicken embryonic cell line chosen for Experiments 2 and 3 was the only 
adherent avian cell line available through ATCC and was therefore selected for the 
avian model experiments.  The ATCC recommended incubation temperature for the 
chicken cell line is 39 °C, however, the average avian body temperature is 41 °C and, 
therefore, 40 °C was selected as a compromise between the 2 temperatures. Although 
fetal bovine serum was a recommended media supplement for both cell lines, chicken 
serum was used for the avian model in keeping with the avian model.   
A variety of media have been used for the cultivation of Encephalitozoon 
(Visvesvara, 2002).  DMEM was the recommended media by ATCC for the chicken 
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cell line and since RK-13 cells have been shown to be successfully maintained in 
different types of media, this medium was selected for both mammalian and avian 
models (Visvesvara, 2002).     
The inocula chosen for Experiment 1, 1.5 x 106 spores/well, and Experiment 2, 
5 x 104 spores/well, were based on parasite to host cell ratios.  Previous in vitro 
experiments evaluating the efficacy of different antimicrosporidial compounds 
inoculated cell layers with either a 3:1 or 4:1 parasite to host cell ratio (Didier et al. 
1998; Bacchi et al. 2002; Sobottka et al. 2002).  Thus, for mammalian model 
Experiment 1, an approximate 4:1 parasite to host cell ratio was used.  For avian 
model Experiment 2, 1 x 104 chicken cells were plated per well because of the rapid 
growth of the cell line.  Since the cells were inoculated with the microsporidia before 
reaching confluency, fewer spores were inoculated per well, 5 x 104.  This resulted in 
a calculated 5:1 parasite to host cell ratio, however, due to the rapid growth of the 
cells, the actual ratio likely approached 4:1.   
For avian model Experiment 3, a fixed number of spores, 1.5 x 106 spores/well, 
was used rather than a parasite to host cell ratio because of the low spore counts that 
resulted during Experiment 2.  It was anticipated that this would allow a better direct 
comparison of growth under mammalian versus avian conditions.   However, the high 
inoculum, approximately 150:1 spore to host cell ratio, resulted in less than favorable 
conditions for parasite growth and typical growth curves were not observed.  In 
addition, a minimal increase in spore numbers was observed over the 16 day 
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experiment.  Therefore, the results of avian model Experiment 3 are not comparable 
with avian model Experiment 2 or the mammalian model.   
E. cuniculi grew better under the mammalian model compared to both isolates 
of E. hellem.  E. cuniculi underwent a shorter lag phase and rapidly entered 
logarithmic growth (day 2) which lasted until day 11.  On the other hand, the E. hellem 
isolates had a longer lag phase and the logarithmic phases of these isolates were not as 
pronounced as that of E. cuniculi.  E. cuniculi produced a maximum number of spores 
at day 11 PI, which was much earlier compared to E. hellem isolates, which produced 
a maximum number of spores at day 20 PI.   
In Experiment 2, where an approximate 4:1 parasite to host cell ratio for the 
inoculum was used, the E. hellem bird isolate had the highest growth curve.  Although 
the E. cuniculi isolate had higher spore numbers than those of the E. hellem human 
isolate, further evaluation of the logarithmic phases of these isolates show that the 
E. hellem human isolate produced a greater number of spores compared to E. cuniculi 
during this phase.  In addition, the slope of the growth curve of human E. hellem was 
comparable to that of bird E. hellem.  Between days 5 and 17 PI, the E. hellem bird 
isolate showed a 15.5 fold increase in the number of spores produced and the 
E. hellem isolate had a 16.5 fold increase, while E. cuniculi only had a 4.5 fold 
increase.   
The lower number of spores seen for the E. hellem human isolate under 
Experiment 2 was also noted in the RK seeded 75 cm2 flasks used to propagate the 
inoculum for the experiment.  This observation led to the speculation that undetected 
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low level contamination was present, and fresh stocks of cryopreserved spores were 
used to propagate all three isolates before proceeding to avian model Experiment 3.     
The results indicate that E. hellem isolates can infect and replicate under 
mammalian and avian conditions.  Although the results do not provide enough 
evidence to support preferential growth of these parasites under the avian model, the 
results do support the potential zoonoses of E. hellem.  In addition, E. cuniculi, a well 
known mammalian parasite showed preferential growth under the mammalian model.   
However, it remains to be determined what variable or variables, i.e. incubation 
temperature, host cell type, or serum, under the avian model had the greatest influence 
on the growth of E. cuniculi.    
Temperature, host cell type, and serum types are 3 factors affecting host 
parasite interactions that have been previously investigated (Taylor and Baker, 1987).  
For microsporidia, temperature influences both the infectivity of spores (Shadduck & 
Polley, 1978; Olson, 1981; Trammer et al. 1999), and the morphological 
characteristics of spores (Trammer et al. 1999). In a study by Trammer et al. (1999) 
the effect of temperature on the in vitro cultivation of Nosema algerae, a 
microsporidian parasite of mosquitoes, was observed.  Parasites were grown in human 
muscle fibroblasts at 31 °C and 38 °C.  At these 2 temperatures there were differences 
in the time until infected cells were detected, as well as in the number of parasites 
produced.   Infected cells were seen after 48 hours PI when cultured at 31 °C and not 
until after 72 hours PI when cultivated at 38 °C.  Additionally, differences in the 
arrangement of the polar filament within spores were also noted (Trammer et al. 
 
 75
1999).  It is possible that a similar effect may have occurred in the current study so 
that under the mammalian model at 37 °C the E. hellem isolates produced a maximum 
spore value later than under the avian model at 40 °C.  Conversely, the higher 
temperature of the avian model may have negatively influenced the growth of 
E. cuniculi, resulting in a logarithmic curve that was not as steep as that in the 
mammalian model.   
Host cell types directly impact in vitro cultivation of parasites.  For the in vitro 
cultivation of Trypanosoma brucei, for example, a slowly growing feeder cell line is 
preferred to a rapidly growing cell line.  Rapidly growing cells deplete the medium of 
nutrients and metabolites accumulate faster, producing less favorable conditions for 
parasite growth (Taylor & Baker, 1987).  Therefore, the rapidly replicating cells of the 
chicken cell line may have provided less favorable growth conditions for the isolates 
under the avian model.  During Experiment 2, it was observed that that the medium 
became increasingly yellow and appeared acidic by 48 hours after old medium had 
been removed and replaced with fresh medium.  After 72 hours the medium was bright 
yellow suggesting a very acidic pH.  The dramatic change in pH was most likely due 
to the increase of metabolites produced by the extremely rapid growth of the chicken 
cells; therefore, the interval between spore harvests was reduced from 3 days to 2 days 
in avian model Experiment 3.  However, whether this change in protocol was helpful 
remains undetermined because a typical growth curve was not produced.  This is 
likely attributable to the elevated spore to host ratio used.    
 
 76
In addition, the growth of E. cuniculi in different cell lines has been evaluated 
and has shown E. cuniculi isolates from a rabbit, mouse and hamster produced a much 
greater number of spores in rabbit choroid plexus cells and canine embryo cells as 
compared to RK-13 cells and primary hamster glial and kidney cells (Montrey, 
Shadduck & Pakes, 1973).  A separate study by Shadduck and Polley (1978) showed 
that higher passaged cells were more easily infected with E. cuniculi.  Based on those 
results the differences in parasite growth reported by Montrey et al. (1973) are most 
likely due to other characteristics rather than the passage level of the cells since some 
of the primary cell cultures produced higher number of spores than different cell lines 
at a higher passage.  The RK-13 cell line and the chicken cell line used in the current 
experiments were both approximately at the same passage level (passage 168), 
therefore, it is more likely that other characteristics of the cells, such as replication 
rates, directly impacted the growth curves of the isolates used in this study.   
Serum is an important supplement for the growth of the host cell as well as the 
growth of the parasite.  FBS has been shown to support a wide range of cell lines and 
has been successfully used in the cultivation of different parasites from different host 
species (Taylor & Baker, 1987).  FBS is the one of the most predominant sera used for 
many in vitro systems.  FBS is versatile in that it can support a wide range of cell 
types and commercially available FBS is reliable in consistency (Mather & Roberts, 
1998).  Avian parasites of the genera Cryptosporidium and Eimeria have also been 
cultured in medium supplemented with FBS (Augustine, 2001; Arrowood, 2002).  
Therefore, a critical experiment to evaluate the avian and mammalian models would 
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be to use FBS in both models as the serum supplement in order to evaluate the 
influence of FBS on parasite growth.     
In order to effectively evaluate the factors influencing the differences in 
growth of the bird and human E. hellem isolates, further experiments are needed.  
Future studies should include a “human” model.  Ideally mammalian, human and 
avian cell lines that can grow equally well at 37 °C and 41 °C need to be used.  This 
would aid in eliminating effects on microsporidian growth caused by differences in 
host cells.  This would also allow for further evaluation of the effects of serum and 
temperature on the microsporidium.   All of the host cell lines should be fully adapted 
to the same basal medium to eliminate any variation due to the medium components.  
The effect of serum types could further be evaluated by conducting a set of 
experiments using different serum types in the same medium and host cells.  Or, 
alternatively, a serum could be selected that reliably supports the growth of the cells 
equally as well for each model.  Also, based on the differences observed between 
avian model Experiments 2 and 3, a spore to host cell ratio must be maintained 
between experiments and the duration of the experiments should be at least 24 days.  
The results of these experiments do not conclusively define preferential growth 
conditions of the E. hellem isolates; however, the results do indicate that E. hellem 
isolates can in fact infect and replicate in mammalian cells at 37 °C as well as avian 
cells at 40 °C, thereby indicating the probable zoonotic potential.  The results of these 
experiments combined with previous molecular genotyping of human and bird E. 
hellem isolates and avian experimental infections show that E. hellem is a parasite of 
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zoonotic potential and the risks of owning pet birds should be explained to 
immunocompromised pet owners.   
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CHAPTER I 
SUMMARY 
 
 
 The E. hellem (bird and human) aminopeptidase sequences presented here 
clearly show that these isolates are nearly identical, providing further molecular 
evidence of the high identity (>99 %) shared between these isolates.  Furthermore, the 
E. hellem and E. cuniculi aminopeptidase sequences obtained share nearly 70% 
identity indicating the enzyme is conserved between species and may be a valid target 
for drug therapy.  No substitutions were observed in regions critical to enzyme 
activity.  The aminopeptidases presented here appear to be homologous with the 
E. cuniculi glutamyl aminopeptidase (GenBank accession no. NP_597136).   
It is likely that the Encephalitozoon aminopeptidases characterized here are 
susceptible to aminopeptidase inhibitors as are other members of the M1 family and, 
therefore, are a potential drug target. However further characterization of the 
aminopeptidase is needed.  The sequence data obtained in this study could be used to 
express a recombinant protein allowing for in vitro screening of different 
pharmaceuticals.  Comparison of the recombinant protein to native protein would 
allow for insight into post translational modifications of the native enzyme.  In 
addition portions of the recombinant protein may also be used to create antibodies 
which can later be tagged with a fluorescent label and used to localize the 
aminopeptidase in vitro.  Molecular sequences have provided evidence of drug 
susceptibility in other organisms in which resistance to certain drugs has been 
correlated to mutations in amino acid sequences (De Stasio & Dahlberg, 1990; Kwa, 
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Veenstra & Roos, 1994; Kwa et al. 1995).  Therefore, it would meaningful to 
sequence this aminopeptidase gene from other microsporidia that infect humans, such 
as E. intestinalis, V. corneae, and E. bieneusi, to predict aminopeptidase susceptibility.  
It would also be advantageous to investigate the role of this enzyme in the parasite life 
cycle and/or host cell and parasite interactions. 
 The results of the in vitro experiments do not conclusively show preferential 
growth of E. hellem under the avian model, however, the results do show that 
E. hellem can infect and replicate equally well under both avian and mammalian 
conditions.  Although further experiments are needed to demonstrate the preferred 
host conditions of these parasites, the results of the in vitro experiments combined 
with the molecular data provide further evidence of the possible zoonoses of these 
parasites.   
   Although bird to human transmission has not been reported, E. hellem 
infections have been documented in humans that owned pet birds.  Furthermore, 
parasite shedding has been documented in asymptomatic pet bird species (Barton & 
Snowden, 2003).  Therefore, immuncompromised individuals should be aware of the 
risk that pet birds could be carriers of E. hellem.     
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APPENDIX I 
 
 
Average number of spores per well for E. hellem bird and human, and E. cuniculi under mammalian and avian models.  The time  
points at which spores were harvested including the day PI which corresponded are listed.   
      
Mammalian model  Experiment 1               
Time Point 1 2 3 4 5 6   8
Days PI 2 5 8 11 14 17 20 23
Eh human 1.5x105     1.3X105 3.8X105 9X105 5.7X105 8.8X105 2.1X106 2.1X106
Eh bird 5.4x104        1.7X105 6.7X105 9.2X105 1.3X106 1.4X106 3.5X106 3.3x106
Ec 2.4x105        4.0X106 1.9X107 3.5X107 1.8X107 1.55X107 1.5X107 9.7x106
        
Avian Model Experiment 2             
Time Point 1 2 3 4 5 6   8
Days PI 2 5 8 11 14 17 20 23
Eh human 6.7x104      2.9X104 8X104 1.2X105 2X105 5.1X105 3.8X105 4.3X105
Eh bird 4.3x104       1.1X105 4.5X105 8.5X105 1.4X106 1.8X106 3X106 1.6X106
Ec 6.2x104        1.6X105 2.5X105 3.3X105 3.4X105 5.4X105 7.3X105 7.5X105
        
Avian Model Experiment 3             
Time Point 1 2 3 4 5 6   8
Days PI 2 4 6 8 10 12 14 16
Eh human 8.5x105      1.4X106 1X106 1.4X106 2X106 1.5X106 1.5X106 2.2X106
Eh bird 5.0x105        1.6X106 1.1X106 8.8X105 1.8X106 1.3X106 1.8X106 2.9X106
Ec 6.1x105      1.9X106 1.1X106 1.3X106 2X106 2X106 2.1X106 2.8X106
 
 
 
104
 APPENDIX II 
 
P-value results of statistical analyses comparing the growth of E. hellem human (EH), E. hellem bird (Mu5), and E. cuniculi (Ec), within experimental 
models.   
    
Mammalian Model Experiment # 1 Avian Model Experiment # 2 Avian Model Experiment # 3 
Isolate  Isolate Time Point p- value Isolate Isolate Time Point p- value Isolate Isolate
Time 
Point p- value
Ec Eh 1 0.5105 Ec Eh 1 1 Ec Eh 1 0.1588
Ec         Mu5 1 0.0019 Ec Mu5 1 0.1811 Ec Mu5 1 0.295
Eh         Mu5 1 0.0087 Eh Mu5 1 0.1811 Eh Mu5 1 0.0214
Ec         Eh 2 <.0001 Ec Eh 2 <.0001 Ec Eh 2 0.1021
Ec         Mu5 2 <.0001 Ec Mu5 2 0.1558 Ec Mu5 2 0.2908
Eh         Mu5 2 0.5619 Eh Mu5 2 <.0001 Eh Mu5 2 0.5277
Ec         Eh 3 <.0001 Ec Eh 3 <.0001 Ec Eh 3 0.983
Ec         Mu5 3 <.0001 Ec Mu5 3 0.0411 Ec Mu5 3 0.9842
Eh         Mu5 3 0.034 Eh Mu5 3 <.0001 Eh Mu5 3 0.9672
Ec         Eh 4 <.0001 Ec Eh 4 0.0004 Ec Eh 4 0.3971
Ec         Mu5 4 <.0001 Ec Mu5 4 0.0007 Ec Mu5 4 0.4026
Eh         Mu5 4 0.7226 Eh Mu5 4 <.0001 Eh Mu5 4 0.1036
Ec         Eh 5 <.0001 Ec Eh 5 0.0554 Ec Eh 5 0.9406
Ec         Mu5 5 <.0001 Ec Mu5 5 <.0001 Ec Mu5 5 0.3712
Eh         Mu5 5 0.0027 Eh Mu5 5 <.0001 Eh Mu5 5 0.4108
Ec         Eh 6 <.0001 Ec Eh 6 0.9912 Ec Eh 6 0.2195
Ec         Mu5 6 <.0001 Ec Mu5 6 <.0001 Ec Mu5 6 0.3717
Eh         Mu5 6 0.1567 Eh Mu5 6 <.0001 Eh Mu5 6 0.7236
Ec         Eh 7 <.0001 Ec Eh 7 0.0097 Ec Eh 7 0.1063
Ec         Mu5 7 0.009 Ec Mu5 7 <.0001 Ec Mu5 7 0.2763
Eh         Mu5 7 0.2678 Eh Mu5 7 <.0001 Eh Mu5 7 0.5408
Ec         Eh 8 0.0091 Ec Eh 8 0.0562 Ec Eh 8 0.3673
Ec         Mu5 8 0.0288 Ec Mu5 8 0.0044 Ec Mu5 8 0.8012
Eh         Mu5 8 0.5362 Eh Mu5 8 <.0001 Eh Mu5 8 0.4963
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Results of statistical analyses comparing the growth of E. hellem human (EH), E. hellem  
bird (Mu5), and E. cuniculi (Ec) between experimental models at days 2, 8, and 14 PI. 
Day PI Isolate Exp. Avg.# Spores Exp. Avg.# Spores P-value 
2 Eh M1 1.5 x 105 A2 6.7 x 104 0.1373 
2 Eh M1 1.5 x 105 A3 8.5 x 105 <.0001* 
2 Eh A2 6.7 x 104 A3 8.5 x 105 <.0001* 
8 Eh M1 3.8 x 105 A2 8.0 x 104 <.0001* 
8 Eh M1 3.8 x 105 A3 1.4 x 106 <.0001* 
8 Eh A2 8.0 x 104 A3 1.4 x 106 <.0001* 
14 Eh M1 5.7 x 105 A2 2 x 105 0.0027* 
14 Eh M1 5.7 x 105 A3 1.5 x 106 <.0001* 
14 Eh A2 2 x 105 A3 1.5 x 106 <.0001* 
 
Day PI Isolate Exp. Avg.# Spores Exp. Avg.# Spores P-value 
2 Mu5 M1 5.4 x 104 A2 4.3 x 104 0.4702 
2 Mu5 M1 5.4 x 104 A3 5.0 x 105 <.0001* 
2 Mu5 A2 4.3 x 104 A3 5.0 x 105 <.0001* 
8 Mu5 M1 6.7 x 105 A2 4.5 x 105 0.308 
8 Mu5 M1 6.7 x 105 A3 8.8 x 105 0.2627 
8 Mu5 A2 4.5 x 105 A3 8.8 x 105 0.0574 
14 Mu5 M1 1.3 x 106 A2 1.2 x 106 0.9379 
14 Mu5 M1 1.3 x 106 A3 1.8 x 106 0.0879 
14 Mu5 A2 1.2 x 106 A3 1.8 x 106 0.1763 
 
Day PI Isolate Exp. Avg.# Spores Exp. Avg.# Spores P-value 
2 Ec M1 2.4 x 106 A2 6.2 x 104 0.0065 
2 Ec M1 2.4 x 106 A3 6.1 x 105 0.0171 
2 Ec A2 6.2 x 104 A3 6.1 x 105 <.0001* 
8 Ec M1 1.9 x 107 A2 2.5 x 105 <.0001* 
8 Ec M1 1.9 x 107 A3 1.3 x 106 <.0001* 
8 Ec A2 2.5 x 105 A3 1.3 x 106 <.0001* 
14 Ec M1 1.8 x 107 A2 3.4 x 105 <.0001* 
14 Ec M1 1.8 x 107 A3 2.1 x 106 <.0001* 
14 Ec A2 3.4 x 105 A3 2.1 x 106 <.0001* 
*p value significant 
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